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The Effects of Glucose Tolerance, Hypertension, and Race on Heart Rate
Variability, QT Interval Duration, and Left Ventricular Hypertrophy in OverweightObese Adolescents
Abstract
The prevalence of childhood obesity has increased remarkably within the past ten years with black youth
disproportionately affected. Childhood obesity is linked to cardiovascular risk. Purposes of this study
were to explore relationships between cardiac autonomic risk factors of heart rate variability (HRV), QT
corrected (QTc) Interval duration, and Cornell voltage measures for left ventricular hypertrophy (LVH) to
body mass index (BMI), relative body mass index (RBMI), and blood pressure (BP) measures, and to
examine the effects of impaired glucose tolerance (IGT), hypertension, and race on these cardiac
autonomic risk factors in overweight-obese adolescents.
Methods: Overweight and obese adolescents (N = 128), ages 11-18 years, (60.2% black, 63.3% female)
were included in this secondary data analysis. During the original study BMI, resting BP, 12-lead
electrocardiogram (ECG), and 24-hour Holter measures were obtained. Overweight was defined as BMI ≥
85th percentile on age-gender specific growth charts and obesity as ³ 95th percentile. Systolic or diastolic
BP > 90th percentile for age, height, and sex was considered elevated BP. An oral glucose tolerance test
(1g of dextrose/kg with a maximum of 75 g) or mixed meal tolerance test [(Sustacal/Boost) (6 kcal/kg,
body weight, max 360 kcal)] was conducted with IGT defined as either a fasting blood glucose ³ 100 and <
126 mg/dl or 2-hr post-load glucose ³ 140 and < 200 mg/dl based on the American Diabetes Association
criteria. Holter data were analyzed for HRV time and frequency domain measures of circadian fluctuation
(SDNN) and parasympathetic function (high frequency; HF) using Multi-parameter Arrhythmia Review
Station (MARS) PC Analysis and Editing system. QTc and Cornell voltage (Sv3 + RaVL) measurements for
LVH were obtained from a 12-lead ECG.
Results: In the total sample, 28% had IGT, 34% had prolonged QTc, 51% met criteria for elevated BP, and
none met Cornell criteria for LVH. BMI and RBMI did not correlate with HRV measures, QTc, or Cornell
voltage. Systolic BP was modestly correlated to Cornell voltage (r = 0.231, p = 0.009). No significant
difference was noted between glucose tolerance groups for HRV (HF, p = 0.25; SDNN, p = 0.108), QTc (p =
0.59), or Cornell voltage (p = 0.33). However, the IGT group tended to have a higher frequency of elevated
BP (64% vs. 47%, χ = 3.047, p = 0.08). There was no significant difference in HF (p = 0.31), SDNN (p =
0.80), and QTc (p = 0.92) between BP groups. However, overweight-obese adolescents with elevated BP
displayed significantly higher measures of Cornell voltage (0.95 mV vs. 0.76 mV, p = 0.004) than nonhypertensive peers. No significant difference was identified between blacks vs. whites for HF (p = 0.106),
QTc (p = 0.599), or Cornell voltage (p = 0.965) measures, however black youth displayed significantly
lower SDNN (p < 0.001). The prevalence of IGT was similar between racial groups (28.57% vs. 27.45%, χ =
0.01, p = 0.890).
Conclusion: Obesity alone is an independent factor for cardiovascular risk. Screening for QTc and LVH
using Cornell voltage measurements for LVH using 12-lead ECG is recommended in all overweight-obese
youth.. Further studies examining a more diverse weight group should be considered.
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ABSTRACT
The prevalence of childhood obesity has increased remarkably within the past ten
years with black youth disproportionately affected. Childhood obesity is linked to
cardiovascular risk. Purposes of this study were to explore relationships between cardiac
autonomic risk factors of heart rate variability (HRV), QT corrected (QTc) Interval
duration, and Cornell voltage measures for left ventricular hypertrophy (LVH) to body
mass index (BMI), relative body mass index (RBMI), and blood pressure (BP) measures,
and to examine the effects of impaired glucose tolerance (IGT), hypertension, and race on
these cardiac autonomic risk factors in overweight-obese adolescents.
Methods: Overweight and obese adolescents (N = 128), ages 11-18 years, (60.2%
black, 63.3% female) were included in this secondary data analysis. During the original
study BMI, resting BP, 12-lead electrocardiogram (ECG), and 24-hour Holter measures
were obtained. Overweight was defined as BMI ≥ 85th percentile on age-gender specific
growth charts and obesity as ≥ 95th percentile. Systolic or diastolic BP > 90th percentile
for age, height, and sex was considered elevated BP. An oral glucose tolerance test (1g
of dextrose/kg with a maximum of 75 g) or mixed meal tolerance test [(Sustacal/Boost)
(6 kcal/kg, body weight, max 360 kcal)] was conducted with IGT defined as either a
fasting blood glucose ≥ 100 and < 126 mg/dl or 2-hr post-load glucose ≥ 140 and < 200
mg/dl based on the American Diabetes Association criteria. Holter data were analyzed for
HRV time and frequency domain measures of circadian fluctuation (SDNN) and
parasympathetic function (high frequency; HF) using Multi-parameter Arrhythmia
Review Station (MARS) PC Analysis and Editing system. QTc and Cornell voltage (Sv3 +
RaVL) measurements for LVH were obtained from a 12-lead ECG.
Results: In the total sample, 28% had IGT, 34% had prolonged QTc, 51% met
criteria for elevated BP, and none met Cornell criteria for LVH. BMI and RBMI did not
correlate with HRV measures, QTc, or Cornell voltage. Systolic BP was modestly
correlated to Cornell voltage (r = 0.231, p = 0.009). No significant difference was noted
between glucose tolerance groups for HRV (HF, p = 0.25; SDNN, p = 0.108), QTc (p =
0.59), or Cornell voltage (p = 0.33). However, the IGT group tended to have a higher
frequency of elevated BP (64% vs. 47%, χ = 3.047, p = 0.08). There was no significant
difference in HF (p = 0.31), SDNN (p = 0.80), and QTc (p = 0.92) between BP groups.
However, overweight-obese adolescents with elevated BP displayed significantly higher
measures of Cornell voltage (0.95 mV vs. 0.76 mV, p = 0.004) than non-hypertensive
peers. No significant difference was identified between blacks vs. whites for HF (p =
0.106), QTc (p = 0.599), or Cornell voltage (p = 0.965) measures, however black youth
displayed significantly lower SDNN (p < 0.001). The prevalence of IGT was similar
between racial groups (28.57% vs. 27.45%, χ = 0.01, p = 0.890).
Conclusion: Obesity alone is an independent factor for cardiovascular risk.
Screening for QTc and LVH using Cornell voltage measurements for LVH using 12-lead
ECG is recommended in all overweight-obese youth. Further studies examining a more
diverse weight group should be considered.
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CHAPTER 1. INTRODUCTION
Overview
Healthy People 2010 identified obesity as a health care priority (Healthy People
2010, 2004). Childhood obesity has reached epidemic proportions in the United States;
25% of children are overweight and 11% obese (Dehghan, Akhtar-Danesh, & Merchant,
2005). Disparities among racial groups for obesity exist, and non-Hispanic black male
and female youth experienced the largest increase in prevalence of obesity between 2003
and 2006 (Centers for Disease Control, 2009). Physical and psychological health is
adversely impacted by excess weight during adolescence (Dehghan et al., 2005). Obesity
is a risk factor for a myriad of chronic diseases, including cardiovascular disease (CVD)
and type 2 diabetes mellitus (T2DM) (Goran, Ball, & Cruz, 2003) with manifestations of
these diseases becoming more prevalent in obese adolescents (Goran et al., 2003). It has
been suggested that childhood obesity accounts for up to 45% of all newly diagnosed
cases of pediatric T2DM (Singhal, Schwenk, & Kumar, 2007). Research suggests the
development of T2DM in overweight-obese adolescents is similar to adults but with
faster progression from impaired glucose tolerance (pre-diabetes) to overt disease (Cruz,
Shaibi, Weigensberg, Spruijt-Metz, Ball, & Goran, 2005), and impaired glucose tolerance
(IGT) has increased among obese children (Cruz et al., 2005; Ryan, 2005).
While it is well documented that diabetes causes cardiac autonomic neuropathy,
(Carnethon, Prineas, Temprosa, Zhang, Uwaifo, & Molitch, 2006; Pappachan, Sebastian,
Bino, Jayaprakash, Vijayakumar, Sujathan, et al., 2008; Perciaccante, Fiorentini, Paris,
Serra, & Tubani, 2006; Scott & Kench, 2004; Valensi, Paries, & Attali, 2003) there is a
paucity of information on the effect of glucose intolerance on autonomic function in
overweight and obese adolescents. Adiposity is linked to impaired cardiac autonomic
function, which may result from the release of vasoactive substances from adipocytes that
modulate sympathetic-parasympathetic balance. The literature supports the linkage
between obesity and diminished parasympathetic measures of heart rate variability
(HRV) in youth (Rabbia, Silke, Conterno, Grosso, De Vito, Rabbone, et al., 2003),
however it is unclear whether adiposity in combination with IGT produces an increased
incidence of cardiac alterations that may lead to sudden cardiac death (Webster & Scott,
1997) in children. Cardiac alterations affected by autonomic dysfunction in overweightobese adolescents addressed within this study include: alterations in HRV, QTc (QT
corrected) duration, and electrical voltage measurements for left ventricular hypertrophy
(LVH).
Heart rate variability changes are reflected in individuals with diabetes because of
the tendency of those diagnosed with T2DM to develop autonomic neuropathy
(McMillian, 2002). QTc Interval duration adjusts according to autonomic nervous
system (ANS) activity (Haapalahti, Viitasalo, Perhonen, Makijarvi, Vaananen, Oikarinen,
et al., 2006). Researchers have identified that there is a significant correlation between
decreased HRV and the presence of LVH, with a decrease in HRV being shown to
correlate with the extent of the hypertrophy present (Alter, Grimm, Vollrath, Czerny, &
Maisch, 2006).
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Despite the rapid increase in childhood obesity and associated health concerns,
medical evaluation and treatment of childhood obesity have not consistently met the
recommended standards (Plourde, 2006). Early diagnosis is essential to prevent the
development of obesity-associated complications. Few research studies have been
conducted examining HRV, QTc, and LVH collectively, and studies examining the
concomitant impact of glucose tolerance, hypertension, and race on these variables in the
overweight-obese adolescent population have not been reported. The current study,
examined relationships between HRV, QTc duration, and electrical voltage measures for
LVH to body mass index (BMI), relative body mass index (RBMI), and blood pressure
measures. In addition, the effect of glucose tolerance, hypertension, and racial
differences on HRV, QTc Interval duration, and electrical voltage measures for LVH in
overweight-obese adolescents was examined.
Purpose of the Study
There is a paucity of research involving HRV, QTc, and electrical voltage
measures for LVH in overweight-obese and pre-diabetic populations, and no published
studies have examined these variables collectively in overweight-obese youth. Therefore,
the purpose of this study was to explore relationships between HRV, QTc duration, and
electrical voltage measures for LVH to BMI, RBMI, and blood pressure measures in
overweight-obese adolescents. Additionally, this study examined the effects of glucose
tolerance, hypertension, and race on HRV, QTc Interval duration, and electrical voltage
measures for LVH in this population.
Aims and Hypotheses
The following specific research aims and hypotheses were addressed:
Aim One
Examine the relationship of HRV, QTc Interval duration, and electrical voltage
measures of LVH to BMI, RBMI, and systolic/diastolic blood pressure measures in
overweight-obese adolescents.
Hypothesis: Higher BMI, RBMI, and increased systolic/diastolic blood pressure
measures will be associated with lower HRV, more prolonged QTc duration, and higher
measures of electrical voltage for LVH.
Aim Two
Compare HRV, QTc Interval duration, and electrical voltage measures for LVH
in overweight-obese adolescents with and without IGT.
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Hypothesis: Overweight-obese adolescents with IGT will exhibit lower HRV
measures, more prolonged QTc duration, and higher electrical voltage measures for LVH
compared to overweight-obese adolescents with normal glucose tolerance.
Aim Three
Compare HRV, QTc Interval duration, and electrical voltage measures for LVH
in overweight-obese adolescents with and without elevated blood pressure.
Hypothesis: Overweight-obese adolescents with elevated blood pressure will
exhibit lower HRV measures, more prolonged QTc duration, and higher electrical voltage
measures for LVH compared to overweight-obese adolescents without elevated blood
pressure.
Aim Four
Compare HRV, QTc Interval, and electrical voltage measures for LVH in black
and white overweight-obese adolescents.
Hypothesis: Black overweight-obese adolescents will display lower HRV, more
prolonged QTc duration, and higher electrical voltage measures for LVH than their white
peers.
Significance of the Study
Increased adiposity has been linked to impaired autonomic dysfunction (Rabbia et
al., 2003), and the ANS either directly or indirectly influences glucose tolerance, blood
pressure, HRV, QTc Interval duration, and LVH.
In individuals with decreased HRV, increases in sympathetic activity have been
shown to increase ventricular arrhythmias (Reed, Robertson, & Addison, 2005). In
conditions where there is increased sympathetic activity and reduced parasympathetic
activity, these are associated in increases in ventricular workload and myocardial oxygen
demand (Soares, Moreno, Cravo, & Nobrega, 2005). This situation increases the
occurrence of ischemia and alters ionic currents throughout the myocardial cellular
membrane, leading to electrical instability (Soares et al., 2005). This electrical instability
can lead to life threatening arrhythmias resulting in sudden cardiac death (Soares et al.,
2005).
A defect in the ion channels located within the heart may cause a delay in
ventricular repolarization (QT syndrome, 2005; Texas Heart Institute, 2007) that is
characterized by prolongation of the QT Interval (Toivonen, 2002). Torsades de Pointes
may follow (Antzelevitch, 2005; Lanjewar, Pathak, & Lokhandwala, 2004; QT
3

syndrome, 2005; Texas Heart Institute, 2007; Toivonen, 2002), and result in sudden
cardiac death (Lanjewar et al., 2004; QT syndrome, 2005).
Fibrosis potentially causes arrhythmias when LVH is present (Kahan, &
Bergfeldt, 2005). Fibers in the enlarged heart muscle become thick and short and
relaxation is decreased, this results in stiff heart muscle that is less able to meet the
body’s demands (Family Blood Pressure Program, 2008). The change in the myocardium
makes it less effective in generating and conducting electrical current throughout the
heart muscle (Corrado, Bacharova, Antzelvitch, & Kanters, 2007). This conduction
defect starts early in LVH and progresses (Corrado et al., 2007). Defects in conduction
can lead to arrhythmias, particularly Torsades de pointes, which may result in sudden
cardiac death (Kahan & Bergfeldt, 2005).
Faulkner, Quinn, Rimmer, and Rich (2005) noted that HRV is decreased in
healthy black youth compared to whites. Limited research on QTc Interval and race has
been published (Science Blog, 2002) and no studies were identified that examined QTc
Interval duration in overweight-obese adolescents in regards to racial differences. Blacks
also have a greater tendency to develop LVH than white peers (Drazner, 2004).
The knowledge obtained from this study contributes significantly to patients and
healthcare by determining associations between HRV, QTc duration, and electrical
voltage for LVH in relation to glucose tolerance, blood pressure status, and/or race in
overweight-obese adolescents. The information obtained enhances general knowledge
for these variables and their relationship to ANS function in overweight-obese
adolescents. Clinically, results from this study may suggest additional risk stratification
is warranted in adolescents and identify whether overweight-obesity with regards to
concomitant glucose intolerance, hypertension, or race alone adversely affect HRV, QTc
Interval duration, and/or electrical voltage measures for LVH.
Conceptual Framework
The developed conceptual framework of this study was centered on ANS
function, obesity, and the interrelated variables: IGT, hypertension, HRV, QTc Interval
duration, and LVH. Obesity may result in autonomic dysfunction and blacks in
comparison to whites have a disproportionately higher prevalence of being overweight
(United States Department of Health and Human Services, 2009). Autonomic nervous
system function may influence HRV (Bilcheck & Berger, 2006), QTc duration (Viitasalo,
Karjalainen, Makijarvi, & Toivonen, 1998), and hypertension (Pal, Pal, Nanda,
Amundharaj, & Karthik, 2009), a risk factor for LVH (Sekine, Izumi, Yamagami, &
Kagamimori, 2001). Independent variables glucose tolerance and hypertension are also
directly affected by the ANS. Sympathetic nervous system stimulation that occurs when
obesity is present has been identified to have a significant impact on overall patient
outcomes. The tendency to develop autonomic neuropathy in diabetes is reflected
through changes in HRV (McMillian, 2002). Autonomic dysfunction can also potentially
result in further increases in blood pressure due to the control of the ANS on blood
4

vessels leading to a hypertensive state, contributing to the occurrence of LVH. Increased
sympathetic stimulation associated with decreases in insulin secretion is also associated
with the occurrence of arrhythmias in people with prolonged QTc Interval duration
(Viitasalo et al., 1998). Although the exact relationship between increased sympathetic
function and obesity has not been identified, researchers have hypothesized that a
significant relationship does exist (Sekine et al., 2001). The conceptual model
hypothesizes that hyperglycemia occurring with IGT may impact autonomic function
even prior to the development of T2DM, and decreased HRV, QT prolongation, and the
development of hypertension a common cause for LVH may follow, resulting in an
increased risk for arrhythmias and sudden cardiac death.
Each of the three variables, decreased HRV (Reed et al., 2005), prolonged QTc
Interval (QT syndrome, 2005), and LVH (Kahan & Bergfeldt, 2005), may lead to the risk
of sudden cardiac death. In individuals with decreased HRV, increases in sympathetic
activity have been shown to increase ventricular arrhythmias (Reed et al., 2005). In
conditions when there is increased sympathetic activity and reduced parasympathetic
activity, there is increased ventricular workload and increased myocardial oxygen
demand (Soares et al., 2005). This increases the occurrence of ischemia and alters ionic
currents throughout the myocardial cellular membrane, leading to electrical instability
(Soares et al., 2005). This electrical instability can lead to life- threatening arrhythmias
resulting in sudden cardiac death (Soares et al., 2005).
Prolonged QT Interval is representative of a delay in ventricular repolarization
(Toivonen, 2002) caused by a defect in the heart muscle cell structures called ion
channels (QT syndrome, 2005; Texas Heart Institute, 2007). The delay in ventricular
repolarization predisposes the heart to arrhythmias, with the most commonly caused
arrhythmia being Torsades de Pointes (Antzelevitch, 2005; Lanjewar et al., 2004; QT
syndrome, 2005; Texas Heart Institute, 2007; Toivonen, 2002), which may result in
sudden cardiac death (Lanjewar et al., 2004; QT syndrome, 2005).
The change in the myocardium when LVH is present makes it less effective in
generating and conducting electrical impulses throughout the heart muscle (Corrado et
al., 2007). This conduction defect starts early in LVH and progresses (Corrado et al.,
2007). The defects in conduction can lead to arrhythmias, particularly Torsades de
Pointes, which may also lead to sudden cardiac death (Kahan & Bergfeldt, 2005). See
Figure 1-1.
Definitions and Major Concepts
Overweight-Obese
Overweight is defined in adolescents as a BMI [(weight (kg) / height2 (m2)] ≥
85th percentile for age and gender, while obesity equates to a BMI ≥ 95th percentile by
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OBESITY
(BLACK YOUTH INCREASED RISK)

AUTONOMIC
DYSFUNCTION

VASOCONSTRICTION

DECREASED
INSULIN
SECRETION

IMPAIRED GLUCOSE
TOLERANCE

DIABETES

AUTONOMIC
NEUROPATHY

PROLONGED QT
INTERVAL

DECREASED
HRV

HYPERTENSION

LEFT VENTRICULAR
HYPERTROPHY

INCREASED RISK FOR SUDDEN CARDIAC DEATH

Figure 1-1. Conceptual Framework of Obesity and Cardiac Risks.
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age and gender percentile distributions (O’Brien, Nader, Houts, Bradley, Friedman,
Belsky, et al., 2007).
According to the Centers for Disease Control (2008), BMI is a dependable
calculation derived from an adolescent’s height and weight to indicate body fatness.
Dual energy x-ray absorptiometry (DXA) and underwater weighing are direct measures
of body fatness but are often expensive and time consuming. (Centers for Disease
Control, 2008). Although BMI does not directly measure body fat, reports have indicated
a significant correlation of BMI to DXA and underwater weighing, and it is a rapid and
inexpensive method of identifying body fatness in adolescents (Centers for Disease
Control, 2008). Relative body mass index (RBMI) is useful in examining children of
various ages and sexes for severity of obesity (Wang, Ge, & Popkin, 2000). It is a
meaningful, continuous variable and represents the BMI divided by a standard BMI for
age and sex and should remain relatively unchanged as age increases (Wang et al., 2000).
Impaired Glucose Tolerance
Impaired glucose tolerance, also referred to as pre-diabetes, was defined
according to American Diabetes Association (2008) criteria (fasting blood glucose ≥ 100
and < 126 mg/dl or 2-hr post-load glucose ≥ 140 and < 200 mg/dl). Thus, individuals
with either elevated fasting or elevated 2-hour post-load glucose, whether measured
during an oral glucose tolerance test or mixed meal tolerance test, were classified as
having IGT.
Determination of IGT is of great significance. Within 10 years of diagnosis, 50%
of adults with IGT progress to T2DM, and the risk of being diagnosed with
cardiovascular disease doubles (Wylie, Hungin, & Neely, 2002). In overweight and obese
youth, the transition between IGT and T2DM is shortened compared to adults (Jolliffe &
Janssen, 2006), which may contribute to earlier manifestations of cardiovascular disease.
Hypertension
The National High Blood Pressure Education Program Working Group on High
Blood Pressure in Children and Adolescent’s normative blood pressure table was used to
determine hypertension. Systolic blood pressure (SBP) or diastolic blood pressure (DBP)
> 95th percentile was considered hypertension, pre-hypertension as > 90th but < 95th
percentile, and non-hypertension as < 90th percentile for age, height, and sex (McNiece,
Poffenbarger, Turner, Franco, Sorof, & Portman, 2007). Pre-hypertension and
hypertension blood pressure groups were then combined to form the elevated blood
pressure group.
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Heart Rate Variability
Heart rate variability is the normal beat-to-beat alterations of heart rate and
reflects the ANS’s ability to respond to the environment (McMillan, 2002). Heart rate
variability measurements were obtained from 24-hour Holter electrocardiogram
recordings and derive from the analysis of consecutive R-R intervals (Gang & Malik,
2003). The predominant method for analysis of HRV is time and frequency domain
analysis, and these measurements also provide information about ANS activity (Gang &
Malik, 2003). Time domain analyses are calculated using mathematical equations, with
measures reflecting parasympathetic modulation and circadian rhythmicity. The time
domain measure utilized within this study is the standard deviation of all RR intervals
(SDNN). This method was used because SDNN is a predictive HRV measure of
mortality (Lampert, Ickovics, Horwitz, & Lee, 2005). Sudden cardiac death has been
linked to SDNN < 50msec (Faulkner, et. al, 2005). Power spectral analysis transforms
variations in RR intervals into frequency waveforms reflecting sympathetic and
parasympathetic modulation. The frequency domain measure used in this study was high
frequency (HF), which reflects parasympathetic modulation (Butera, Bonnet, Kachaner,
Sidi, & Villain, 2003). The HF measure was chosen for this study because it represents
parasympathetic function exclusively (Faulkner et al., 2005). The low frequency measure
represents a mixture of sympathetic and parasympathetic function (Faulkner et al., 2005)
and therefore is not representative of sympathetic or parasympathetic function alone.
Karavanaki-Karanassiou (2001) suggested that abnormalities in cardiac parasympathetic
regulation precede impairment of blood vessels sympathetic control in youth with
diabetes.
QT Interval
The QT Interval represents ventricular depolarization, and repolarization and is
the measurement from the onset of the QRS complex to the end deflection of the T wave
(Furukawa, Shimizu, Hiromoto, Kanemori, Masuyama, & Ohyanagi, 2006; Hunt, 2005).
The QT Interval normally ranges from 0.2-0.4 sec and is often corrected to be
independent of heart rate. According to the Harriet Lane Handbook 14th edition (Barone,
1996), the QTc should not exceed 0.440 sec in children and 0.425 sec in adolescents and
adults. The QT Interval adjusts to changes in heart rate (Barone, 1996; Moss & Allen,
2001), and for comparison at different heart rates, correction formulas were developed to
determine the QTc Interval, and Bazett’s formula is used most often (Malik, Färbom,
Batchvarov, Hnatkova, & Camm, 2002).
Left Ventricular Hypertrophy
Left ventricular hypertrophy is enlargement of the ventricles (American Heart
Association, 2007). This enlargement is often related to an increased workload on the
heart muscle, which could be related to obesity or hypertension. The increased vascular
resistance in the hypertensive person causes the heart to increase its workload and
therefore the muscle enlarges to accommodate the body’s requirement.
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Normative values have not been established in overweight or obese youth for
electrical voltage measures for LVH. However, in obese adults, when using Cornell
voltage criteria, in men when SV3 + RaVL > 2.8 mV and in women > 2.0 mV, LVH was
considered. Cornell voltage criterion (SV3 + RaVL) has increased specificity and
sensitivity in obese individuals, making this measure of LVH an appropriate choice.
Assumptions
The following assumptions were made for the purpose of the study:
•
•
•
•
•
•
•

Impaired glucose tolerance in adolescents has a similar pathology to that
identified in adults.
Impaired glucose tolerance produces changes in autonomic function beyond that
conferred by obesity.
There are not significant age and gender differences in HRV among overweightobese adolescents.
The Cornell criterion for measurement of LVH is appropriate for overweight and
obese youth.
Placement of the electrocardiogram leads for the 12-lead electrocardiogram and
24-hour Holter recording allowed for accurate electrocardiographic measurements
in this sample of overweight-obese adolescents.
Participants were compliant with the 10-hour fast prior to the oral glucose
tolerance test conducted within the original study as advised, allowing accurate
determination of glucose tolerance status.
Anthropometrics data were accurately measured and recorded during the initial
data collection period.
Limitations

Utilization of secondary data analysis was suitable for the research problem,
although this design has both strengths and limitations. The secondary analysis of data
allows the researcher to focus on a subgroup of the original sample to examine specific
questions on readily available data. There are several limitations to the use of secondary
analysis of data for completion of this study.
•
•

•

The researcher had to assume the quality of the data was acceptable and was
originally collected accurately and in congruence with the aims of the original
researcher.
Literature suggests that Cornell voltage (SV3 + RaVL) is less influenced by the
presence of obesity (Eckel, 2003), in adults. However, normative standards have
not been developed for overweight-obese adolescents, and the use of adult
standards may limit the results of this study.
Age variations for HRV may exist (Faulkner, Quinn, Rimmer, & Rich, 2005),
however, the sample was too small to conduct sub-analysis by age.
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•

Hypertension status was determined based on single blood pressure readings
rather than multiple measurements, and room temperature or stress could
influence study findings.

While these are limitations it was appropriate to examine these measures because they
have not been previously examined in overweight and obese youth. In addition, results
could suggest further investigation of these variables is warranted in overweight-obese
youth.
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CHAPTER 2. REVIEW OF LITERATURE
Introduction
In the United States 25% of children are overweight and 11% are obese (Dehghan
et al., 2005). This epidemic disease has transcended all racial groups with an exaggerated
prevalence in non-whites (Caprio, Daniels, Drewnowski, Kaufman, Palinkas,
Rosenbloom, & Schwimmer, 2008). The incidence of childhood overweight-obesity has
increased substantially within the United States, accompanied by the risk for the
development of many secondary conditions that may progress into adulthood. While
most complications of childhood obesity develop over the course of years, cardiovascular
health risks and IGT may present at a younger age with the progression from IGT to
T2DM shortened (Jolliffe & Janssen, 2006). However, there is limited information on the
effect of obesity on autonomic function in youth.
This review of literature integrates relevant concepts proposed in the conceptual
framework. The first section provides an overview of adolescent obesity. Subsequent
sections address autonomic nervous system function in adolescents by examining HRV,
QT Interval duration, hypertension, and LVH variations based on age, gender, race, and
obesity. Following those sections is an examination of the effects of IGT with
concomitant obesity on autonomic function.
Obesity in Adolescents
The National Health and Nutrition Examination Survey, a representative sample
of the United States population, found 17.6% of adolescents are obese (Centers for
Disease Control, 2009). Childhood obesity is associated with obesity as an adult (Guo,
Wu, Chumlea, & Roche, 2002), and multiple studies link childhood obesity to subsequent
morbidity and mortality in adulthood (DiPietro, Mossberg, & Stunkard, 1994; Must,
Jacquez, Dallal, Bajema, & Dietz, 1992; Nieto, Szklo, & Comstock, 1992). A
longitudinal follow-up of adolescents in the Harvard Growth Study documented that
being an overweight adolescent male increased relative risk of all-cause mortality (RR =
1.8) and mortality from coronary heart disease (RR = 2.3) regardless of weight at age 55
(Must, Jacquez, Dallal, Bajema, & Dietz, 1992).
Obesity is a risk factor for a myriad of chronic diseases including cardiovascular
disease (CVD) and T2DM, and these conditions are now being found in obese children
(Goran, Ball, & Cruz, 2003; Khositseth, Suthutvoravut, Chongviriyaphan, &
Ruangkanchanasetr, 2006). It has been reported that while most complications of
childhood obesity develop over the course of years, cardiovascular health risks and IGT
may present at a younger age, with the progression from IGT to T2DM shortened
(Jolliffe & Janssen, 2006). Fifty-eight percent of overweight children have at least one
cardiovascular risk factor or an elevated insulin level, and up to 25% have two risk
factors or more (Plourde, 2006). Yet there are very few studies in obese children that
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examine autonomic function (Kaufman, Kaiser, Steinberger, & Kelly, 2007),
cardiovascular function (Khositseth, Suthutvorvut, Chongviriyaphan, &
Ruangkanchanasetr, 2006), or electrocardiographic changes. The health problems that
emerge secondary to obesity in children may progress throughout their lifespan (Obesity
Society, 2009), and early prevention and screening by healthcare providers is essential if
childhood obesity is suspected.
Acceptable screening methods that can be used to assess for childhood obesity
include BMI [(weight (kg) / height2 (m2)] and RBMI [BMI / (BMI50th percentile for age
and sex * 100)]. In adolescents, overweight is defined as a BMI ≥ 85th percentile and
obesity as a BMI ≥ 95th percentile based on age, height, and gender percentile
distributions (O’Brien et al., 2007). Although BMI is not a direct measure of body
fatness, BMI is noninvasive, highly reliable, (Centers for Disease Control, 2008), and
found to be related to obesity-associated complications (Rubenstein, 2005). Normative
values for BMI vary by age and gender, making comparisons across groups difficult.
However, RBMI is a continuous variable derived from BMI which provides a measure of
obesity severity and is useful for tracking obesity progression and which facilitates
comparison across age and sex groups (Velasquez-Mieyer, Perez-Faustinelli, & Cowan,
2005; Wang et al., 2000). Relative body mass index could prove to be beneficial for
clinicians monitoring obesity in the aging child (Velasquez-Mieyer et al., 2005). As a
child ages, the amount of expected body fat changes; however, RBMI remains relatively
stable as age increases (Wang et al., 2000). Despite overwhelming evidence suggesting
that BMI and RBMI measures are noteworthy in screening for obesity, a survey of
pediatricians found that only 29% of pediatricians routinely assessed BMI (Flower,
Perrin, Viadro, & Ammerman, 2007), supporting contentions that overweight-obesity is
often under diagnosed in adolescents.
Current screening recommendations for obese children include healthcare
providers performing a full examination with history, lipid profile, blood pressure
measurement, and screening for T2DM (Plourde, 2006) using fasting insulin and glucose
levels. However, IGT is diagnosed more effectively with an oral glucose tolerance test
than fasting blood sugar alone (Cruz et al., 2005), and should be considered when
examining obese youth for IGT. Researchers have suggested that current screening
recommendations in obese youth underestimate risk for diabetes and cardiovascular
disease. Examination of additional risk factors is warranted, particularly in minority
populations where the disease burden is greater (Velasquez-Mieyer, Niera, Nieto, &
Cowan, 2007). Examination of cardiac risk factors of HRV, QTc duration, and electrical
voltage measures of LVH, which are modulated by autonomic function, may aid in
identifying obese youth at increased risk for obesity-associated co-morbidities.
Autonomic Nervous System Function
Sympathetic and parasympathetic stimulation of the ANS regulates cardiac
muscle, smooth muscle, and glands of the body. The ANS is part of the efferent output
of the energy balance pathways that mediates changes in energy expenditure vs. storage
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(Lustig, 2001), and associations between sympathetic stimulation and obesity have been
identified (Sekine et al., 2001). Obesity is usually associated with increased sympathetic
nervous system activity, which may be important in the development of the
cardiovascular sequelae seen in many obese individuals. Conversely, postprandial insulin
hypersecretion has been postulated to be driven by parasympathetic activation of the
pancreatic beta cells through the pancreatic branch of the vagus nerve (Lustig, 2003).
Over time, chronic sympathetic stimulation may inhibit insulin secretion from the beta
cells (Carnethon et al., 2006), further contributing to insulin resistance and IGT.
Investigators examining cardiac autonomic function in obese adults have reported a
relative decrease in parasympathetic function in comparison to sympathetic function
(Gutin, Barbeau, Litaker, Gerguson, & Owens, 2000). These studies suggest that both
alterations in sympathetic and parasympathetic activity occur in concert with obesity.
Whether alterations in ANS function contribute to obesity or are a consequence of
obesity remains unknown (Tentolouris, Liatis & Katsilambros, 2006).
The ANS regulates heart rate and blood pressure. Epinephrine and norepinephrine
released by the sympathetic nervous system and acetylcholine released by the
parasympathetic nervous system are major influences on heart rate and rhythm (Alter et
al., 2006). Therefore, in light of cardiac automaticity, heart rate is largely controlled by
ANS function (Alter et al., 2006). Factors affecting cardiac autonomic function
examined within this study included HRV, QTc duration, hypertension, and electrical
voltage measures for LVH.
Heart rate variability is the normal beat-to-beat alterations of heart rate and
reflects the autonomic nervous system’s ability to respond to the environment (McMillan,
2002). It is modulated by both sympathetic and parasympathetic activity (Bilchick &
Berger, 2006). The QT Interval is the measurement from the onset of the QRS complex
to the end deflection of the T wave and represents ventricular depolarization and
repolarization (Furukawa et al., 2006; Hunt, 2005). It is also modulated by autonomic
function (Viitasalo et al., 1998). Hypertension, a risk factor for the development of LVH,
is associated with sympathovagal imbalance and vagal withdrawal (Pal et al., 2009).
Heart Rate Variability
Limited information regarding HRV in healthy adolescents has been reported;
thus large data sets are not available for the establishment of normative values.
Additionally, comparisons across studies have been hindered by varying methods used to
collect HRV data, with measurements being derived from ranges of 24-hours to as little
as 5-minute time periods.
Heart Rate Variability: Age and Gender Effects
Massin and Von Bernuth (1997) and Silvetti, Drago, & Ragonese (2001) reported
that HRV measures of circadian fluctuation increased from infancy through early
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adolescence along with associated maturational decreases in heart rate. Similarly,
Galeev, Igisheva, & Kazin (2002) found that in children 6 to 16 years of age, circadian
fluctuation (SDNN values) increased with age, as did high frequency (HF) values,
reflecting increased parasympathetic function.
Contradictory findings on gender differences for HRV have been reported in the
literature and may be reflective of small sample sizes for various age groups, differences
in measurement techniques, and/or the effect of physical activity levels on HRV
measures. Faulkner, Hathaway, and Tolley (2003) examined gender differences in HRV
and reported adolescent males (n = 26) exhibited higher circadian fluctuation (SDNN)
and higher parasympathetic function (HF) measures than adolescent females (n = 49).
Similarly Silvetti, Drago, & Ragonese (2001) reported greater circadian rhythmicity,
measured by SDNN, in males compared to females. In contrast, Galeev, Igisheva, &
Kazin (2002) reported gender differences in HRV measures of low frequency and SDNN
during early adolescence, which disappeared at 16 years of age.
Heart Rate Variability: Racial Differences in Children
Black adolescents, in comparison to white peers, have been noted to have lower
HRV measures of circadian fluctuation (SDNN) and parasympathetic function (HF),
although values were not significantly different (Faulkner et al., 2003). Similarly, Gutin,
Howe, Johnson, Humphries, Snieder, and Barbeau (2005) found lower parasympathetic
(HF) measures in black adolescents compared to whites and also a lower low frequency
(LF): high frequency (HF) ratio after adjusting for age. Contrary to these findings in
youth, black adults had higher measures of parasympathetic function (HF) than whites
and also lower sympathetic (LF) function (Liao, Barnes, Chambless, Simpson, Sorlie, &
Heiss, 1995). Similarly, a small group of healthy black male adolescents were reported to
have a diminished sympathetic tone compared to white peers (Urbina, Bao, Pickoff, &
Berenson, 2002). The majority of studies were not sufficiently powered to examine
multiple covariates, which include physical fitness, physical activity, obesity, and
hypertension that could affect HRV measures. However, collectively these studies
suggest that race should be considered when assessing HRV in adolescents.
Heart Rate Variability and Childhood Obesity
Cross-sectional studies have shown that HRV measures of parasympathetic
nervous system function are decreased in obese children compared to normal weight
children, although contradictory findings have been reported regarding the relationship of
obesity to sympathetic measures and sympathetic/parasympathetic balance (Kaufman et
al, 2007; Martini, Riva, Rabbia, Molini, Ferrero, Cerutti, et al., 2001; Rabbia et al., 2003;
Sekine et al., 2001). The majority of these studies have consisted of small sample sizes.
Kaufman et al (2007) examined HRV measures in normal weight (n = 10), overweight (n
= 10), and obese (n = 16) 10-13-year old youth using 5-minute resting electrocardiogram
data. Obese children exhibited a significantly higher low frequency (LF)/high frequency
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(HF) ratio indicating sympathetic predominance and lower parasympathetic measures
(HF) compared to normal weight children, and there was a trend (p < 0.07) toward lower
measures of circadian fluctuation (SDNN). The obese children were also more insulin
resistant and had higher systolic blood pressures (Kaufman et al., 2007). Similarly, a
study of school-aged Japanese children matched for age, gender, and height found obese
children (n = 42) had significantly lower LF and HF HRV measures compared to normal
weight peers (n = 42), suggesting both sympathetic and parasympathetic function are
diminished in obese youth (Nagai, Matsumoto, Kita, & Moritani, 2003). Additionally, in
the presence of autonomic imbalance, decreases in SDNN have been reported in
overweight adolescents (Guizar, Ahuatzin, Amador, Sanchez, & Romer, 2005).
The pattern of sympathetic and parasympathetic dysfunction may be affected by
the duration of obesity. Obese adolescents (n = 50) were stratified based on duration of
obesity and compared to 12 lean peers (Rabbia et al., 2003). Parasympathetic measures
were lower in obese youth, regardless of duration of obesity, compared to normal weight
youth. However, compared to the normal weight group, only the recently obese group
exhibited a significantly higher LF and LF: HF ratio, reflecting higher sympathetic
function and higher sympathetic/parasympathetic balance (Rabbia et al., 2003).
Consistent with these findings, Nagai et al (2003) reported that longer duration of obesity
was associated with lower LF and HF measures of HRV.
The literature supports the beneficial effect of weight loss and fitness training on
HRV measures. Obese adults treated with either bariatric surgery or dietary management
were studied to determine the effect of weight loss on HRV measures (Karason,
Mølgaard, Wikstrand, & Sjöström, 1999). Weight loss in the surgical group was 32 kg
compared to no change in the dietary group, and the surgical group demonstrated
improvements in blood pressure, decreases in norepinephrine excretion, and improved
sympathetic and parasympathetic measures (Karason et al., 1999). Recently published
studies involving small numbers (n = 10-12) of adults undergoing bariatric surgery for
weight loss have reported post-surgery weight loss increases in circadian fluctuation
(SDNN) (Bobbioni-Harsch, Sztajzel, Barthassat, Makoundou, Gastaldi, Sievert, et al.,
2009; Nault, Nadreau, Paquet, Brassard, Marceau, Marceau, et al., 2007),
parasympathetic function (HF) and sympathetic function (LF) (Nault et al., 2007). No
studies were found examining the effect of weight loss alone on HRV in obese youth.
In older adults ( > 50 years of age), regular physical activity appears to attenuate
the negative effects of obesity on HRV measures (Felber, Ackermann-Liebrich,
Schindler, Barthélémy, Brändli, Gold, et al., 2008). Baseline and 10-year follow-up
HRV, BMI, and physical activity measures were assessed in 1,712 adults to determine the
relationship between these variables and the effect of weight gain on changes in HRV
measures. Compared to sedentary obese adults, sedentary normal weight adults had a
14% higher SDNN, while normal weight exercisers and obese exercisers had a 19%
higher SDNN (Felber et al., 2008).
Lower sympathetic and parasympathetic measures of HRV have been reported in
obese youth compared to normal weight youth, controlling for physical activity, age,
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gender, and height (Nagai & Moritani, 2004). In one of the few reports involving a
mixed racial sample of 304 adolescents from the United States, the relationship of
physical activity and adiposity to HRV measures was examined, controlling for age, race,
and gender (Gutin, Howe, Johnson, Humphries, Snieder, & Barbeau, 2005). Engagement
in more vigorous physical activity and lower adiposity was associated with a more
favorable HRV profile, with higher adiposity having a more deleterious effect on HRV in
black than in white youth (Gutin et al., 2005). Exercise training programs improve
parasympathetic function (HF) in obese adolescents (Gutin et al., 2000) and reduce the
ratio of sympathetic to parasympathetic activity (Gutin, Owens, Slavens, Riggs, &
Treiber, 1997).
Summary of Studies Examining Heart Rate Variability
Heart rate variability measures change during childhood as a result of maturation,
with HF and SDNN values stabilizing during adolescence when normal heart rate values
reach adult values. Contradictory findings on gender and racial differences in HRV
measures have been reported. Obesity is associated with lower HRV measures of
sympathetic and parasympathetic function, with duration of obesity affecting the
relationship between obesity and sympathetic function. Physical activity improves
parasympathetic function and results in a more favorable sympathetic/parasympathetic
balance. Physical activity may also attenuate some of the obesity-associated decreases in
HRV measures.
QT Interval Duration
The QT Interval, measured from the onset of the QRS complex to the end of the T
wave, represents ventricular depolarization and repolarization (Furukawa et al., 2006;
Hunt, 2005) and is modulated by autonomic nervous system function (Viitasalo et al.,
1998). The autonomic nervous system influences both cardiac repolarization and QT
length directly through its effect on heart rate.
Prolongation of the QTc Interval (delay in ventricular repolarization) predisposes
the heart to arrhythmias, with the most commonly caused arrhythmia being Torsades de
Pointes (Antzelevitch, 2005; Lanjewar et al., 2004; QT Syndrome, 2005; Texas Heart
Institute, 2007; Toivonen, 2002;). Torsades de Pointes can lead to sudden cardiac death
(Lanjewar et al., 2004; QT Syndrome, 2005). Although prolonged QTc duration
increases the individuals overall probability of arrhythmias the critical threshold is
suggested to be 0.550 sec (Suys, Heuten, De Wolf, Verherstraeten, de Beeck, Matthys, et
al., 2006). While long QT syndrome has been studied in youth, there is a paucity of
information on QTc Interval duration in obese youth and on the relationship of QTc
duration to other cardiac autonomic measures.
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QT Interval Duration: Age and Gender Effects
The QT Interval normally ranges from 0.2-0.4 sec and adjusts to changes in heart
rate (Barone, 1996; Moss & Allen, 2001). It has been noted that considerable heart rate
variations are present throughout childhood, which makes correction of the QT Interval
in children essential (Prasad, Furr, Zhang, Ball, & Allen, 2007). Bazett’s correction
formula is often used to calculate the corrected QT (QTc) Interval, which adjusts for
heart rate (Malik et al., 2002). This correction formula is easy to use but has been known
to over correct at extremely fast heart rates and under correct at very slow heart rates
(Desai, Li, Desta, Malik, & Flockhart, 2003); however, research suggests that there is no
optimal correction formula (Malik et al., 2002).
According to the Harriet Lane Handbook 14th edition (1996), the QTc should not
exceed 0.44 sec in children and 0.425 sec in adolescents and adults. When using the 12lead electrocardiogram, the QT Interval is often obtained manually by measuring 3
consecutive QT Intervals in lead II and correcting for heart rate utilizing Bazett’s formula
(Rana, Lim, Naas, Ogston, Newton, Jung, et al., 2005). Prolongation of the QT Interval is
strongly related to sudden cardiac death and the autonomic nervous system influences
diurnal variation (Yeragani, Berger, Pohl, & Balon, 2005).
Prior to puberty, QT Interval duration is similar between genders; however, at
puberty, the QTc Interval shortens in boys, and a variation in the pattern of ventricular
repolarization is seen between genders (Surawicz & Parikh, 2003). These findings of
shorter QTc Intervals in boys are consistent with data reported by Pearl (1996). In a
sample of 781 healthy 10-18 year olds, Pearl (1996) found that QTc Intervals were
greater in girls than boys across age ranges, and QTc varied inversely with age and
directly with heart rate.
QT Interval Duration: Racial Differences in Children
There is a paucity of research examining QT Interval duration and race in
adolescents. However, a study in adults suggests that QTc is shorter in healthy blacks
than whites (Dekker, Crow, Hannan, Schouten, & Folsom, 2004). Challenging these
findings, researchers identified contrary results but acknowledged a small sample size as
a possible limitation (Sgarbossa, Pinski, Williams, Pavlovic-Surjancev, Tang, &
Trohman, 2000). Researchers have also suggested that race in general is not considered a
risk factor for QT prolongation (Peeters, Janssen, Kakuda, Scholler-Gyure, Lachaert,
Hoetelmans, et al., 2008). Although conflicting results have been identified in adults,
published studies examining race and QT Interval duration in overweight-obese
adolescents were not identified during this review of literature.
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QT Interval Duration and Childhood Obesity
Obese individuals are at an increased risk for the development of arrhythmias
associated with QT Interval prolongation (El Gamal, Gallagher, Nawras, Gandhi, Gomez,
Allison, et al., 1995). Through direct neural effects on the heart, the ANS influences QT
Interval duration (Haapalahti et al., 2006), potentially leading to lethal arrhythmias. Most
individuals with prolonged QT Interval duration are at risk for cardiac arrhythmias during
sympathetic stimulation as a result of increases in heart rate (Haapalahti et al., 2006).
Obesity may be one of the most common causes of prolonged QT duration, with
significant associations to RBMI (El Gamal et al., 1995) as well as a positive association
between BMI and QT Interval duration (Poirier, Giles, Bray, Hong, Stern, Pi-Sunyer, et
al., 2006). Similarly, Spanish obese youth (n = 30) exhibited longer QTc, greater volume
and mass of the left ventricle, and greater risk of arrhythmias compared to normal weight
youth (n = 30) (Olivares Lopez, Vazquez Olivares, Fleta Zaragozano, Moreno Aznar,
Bueno Sanchez, 2005). Contrarily, some researchers have noted a lack of correlation
between QT Interval and BMI (Fukushige, Yoshinaga, Shimago, Nishi, Kono, Nomura,
et al., 2002; Girola, Enrini, Garbetta, Tufano, & Cariezel, 2001). The majority of studies
examining the relationship of weight to QT Interval duration have been conducted in
non-United States (US) populations; thus studies examining relationships between BMI
and QTc Interval duration in US adolescents are needed.
QT Interval Duration and Heart Rate Variability
Few studies have examined relationships between QT Interval duration and HRV,
and literature identified were more likely to examine these variables in conjunction with
one another rather than in relation to one another (Bilan, Witczak, Palusinski, Ignatowicz,
& Hanzlik, 2005). Circadian variation of autonomic tone is believed to affect QT Interval
duration (Ishida, Nakagawa, Fujino, Yonemochi, Saikawa, & Ito, 1997). High frequency
component, overall HRV measures, and QT Interval duration have shown to correlate in
adult subjects (Viitasalo et al., 1998). A negative correlation with R-R interval and high
frequency power (reflecting parasympathetic function) for QT Interval duration has been
reported in adults (Ishida et al., 1997). Nonetheless, Viitasalo and colleagues (1998) have
indicated that the QT Interval is modulated by autonomic function, which supports
simultaneous examination of these variables in overweight-obese adolescents.
Summary of Studies Examining QT Interval Duration
Age and gender may affect QTc Interval duration during childhood. However, age
effects are attenuated during adolescence, and gender differences manifest, with postpubescent males tending to have a shorter QTc duration than females of similar age.
Contradictory findings have been reported when examining racial differences in QTc
Intervals; thus further investigation in this area is warranted. Obesity and QTc duration
are positively correlated, although QTc duration may fall within the upper limits of
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normal in obese youth. Studies examining the relationships between HRV measures and
QTc Intervals in adolescents were not found. However, adult studies suggest lower HRV
measures of parasympathetic function and circadian fluctuation are associated with
longer QTc Intervals.
Left Ventricular Hypertrophy
Neuroreceptors of the autonomic nervous system located on heart muscle can
affect heart rate, contraction, conduction, and automaticity. Autonomic dysfunction may
result in increased blood pressure due to increased sympathetic outflow to blood vessels,
leading to vasoconstriction and a hypertensive state, thus contributing to the occurrence
of LVH. Periods of sympathetic nervous system arousal are expected in day-to-day
activity, although prolonged stimulation of the sympathetic nervous system is often
characterized as a contributing factor to hypertension (McMillan, 2002) due to resulting
vasoconstriction. The increased vascular resistance in the hypertensive person causes the
heart to increase its workload; therefore, the muscle enlarges to accommodate the body’s
requirement, which is known as LVH.
Left Ventricular Hypertrophy and 12-Lead Electrocardiogram Criteria
Typically the echocardiogram (Gertsch, 2004) or magnetic resonance imaging
(Alfakih, Walters, Jones, Rigway, Hall, & Sivananthan, 2004) are used as the preferred
diagnostic methods of LVH. The suggested electrocardiographic criteria for diagnosing
LVH may be either voltage or non-voltage criteria, although there is no preferred method
(Edhouse, Thakur, & Khalil, 2002). The 12-lead electrocardiogram has been validated as
a measure of detecting LVH compared to the echocardiogram and magnetic resonance
imaging methods; however, it is not recommended that the electrocardiogram be used
alone to diagnose LVH (Pewsner, Juni, Egger, Battaglia, Sundstrom, & Bachmann,
2007). The electrocardiogram is an excellent screening measure and is valued as an
initial diagnostic test for left ventricular hypertrophy (Rijnbeek, van Herpen, Kapusta,
Ten Harkel, Witsenburg, & Kors, 2008). While none of these tests are routinely
performed in children, the electrocardiogram is performed more frequently than
echocardiogram and magnetic resonance imaging and can also detect rhythm or
conduction defects.
When used as a screening tool, the electrocardiogram can be extremely beneficial.
Early detection of LVH is very important in children, because if left undiagnosed and
untreated, the risk of sudden cardiac death is greatly increased. Other benefits of using
the electrocardiogram for early detection of LVH include the ability to interpret the
results more rapidly, cost savings (as the electrocardiogram is estimated to cost only 20%
of the amount for an echocardiogram), and specificity is equivalent to that of the
echocardiogram (approximately 90%). However, the sensitivity or likelihood of false
positive results is 20-35% using the electrocardiogram to detect LVH (Gertsch, 2004).
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The Cornell voltage index is a more recently published criterion for measuring
LVH by electrocardiogram. It has been shown to be more effective in measuring LVH in
obese adults than other criteria (Eckel, 2003). But like many other electrocardiographic
criteria that have been shown to improve detection of LVH in adults, this criteria has not
been tested in children (Rijnbeek et al., 2008).
Left Ventricular Hypertrophy: Age and Gender Effects
Normative values of electrical voltage measures for LVH have not been
established in healthy or overweight-obese children, based on age or gender. However, it
is clearly stated within the literature that adolescent girls have lower amplitude for Q, R,
and S wave, in regards to size or body mass index (Semizel, Ozturk, Bostan, Cil, & Ediz,
2008). Fatty tissue over the chest during growth, which includes breast tissue in girls,
could be related to the lower amplitude in girls (Semizel et al., 2008). The Cornell
voltage criteria for LVH provide gender-specific cut points, which correlate with
echocardiogram and magnetic resonance imaging of LVH (Alfakih et al., 2004). Left
ventricular hypertrophy is diagnosed when electrocardiogram voltage (SV3 + RaVL)
exceeds 2.8 mV in men and exceeds 2.0 mV in women. Cornell voltage criterion (SV3 +
RaVL) is affected far less by the presence of obesity and should be used in adults when
obesity is present (Eckel, 2003). However, it is unknown whether these voltage cut
points of LVH in adults are relevant in adolescence.
Left Ventricular Hypertrophy: Racial Differences in Children
Cardiovascular mortality resulting from LVH is greater in blacks than whites,
which may be related to the higher incidence of hypertension in blacks vs. whites
(Coughlin, Gottdiener, Baughman, Wasserman, Marx, Teft, et al., 1994; Drazner, 2004).
However, regardless of race, childhood obesity is associated with a clustering of
cardiovascular risk factors, including hypertension (Caprio et al., 2008). Investigations
are needed to determine if race affects the development of LVH, particularly in the
presence of concomitant obesity and hypertension, in adolescents, because early
identification and treatment may prevent cardiac mortality.
Left Ventricular Hypertrophy and Childhood Obesity
Flynn and Alderman (2005) reported a linkage between obesity, hypertension, and
LVH, it has also been noted that LVH may develop very early in obese adolescents
(Khositseth et al., 2006). Researchers reported that children who appeared to be a
healthy weight but were actually overweight, had begun to develop LVH, a fact that
stresses the importance of BMI calculation in relation to screening for LVH (Cincinnati
Children’s, 2007).
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In obese individuals, electrical forces within the heart become more posterior, and
the SV3 is the most representative voltage for evaluating posterior electrical forces (Eckel,
2003). When LVH is present, the heart in obese individuals is shifted more horizontally
in the chest cavity, which elucidates the importance of the RaVL (Eckel, 2003), part of the
Cornell criteria for LVH.
The most common cause of LVH is systemic hypertension (Edhouse et al., 2002).
In 34-38% of children with even mild untreated hypertension, LVH has been identified
and childhood obesity is an additional risk for the development of LVH (Ippisch &
Daniels, 2008). Khositseth and colleagues (2006) have shown no correlation between
high blood pressure and obesity or severity of obesity, though this could be related to the
small number of participants who were hypertensive and the relatively small sample size.
Interestingly, in a small study of Spanish obese youth (n = 30) a greater volume and mass
of the left ventricle compared to normal weight youth was exhibited (n = 30); however,
information on the hypertensive status of the children was not available (Olivares Lopez
et al., 2005).
Left Ventricular Hypertrophy/Hypertension and Heart Rate Variability
There is a paucity of research examining HRV in the presence of LVH. Studies
were not identified that examined these variables collectively in adolescents. In one
study, adults with concomitant hypertension and hypertrophic cardiomyopathy had
reduced SDNN measures of HRV, with greater reductions in HRV linked to increased
hypertrophy (Alter, Grimm, Vollrath, Czerny, & Maisch, 2006). In contrast, another
study noted no significant differences in HRV measures when mild hypertension was
present (Franchi, Lazzeri, La Villa, 1996). Studies examining the relationship of HRV to
hypertension have yielded equivocal results, which may be partially attributed to the
confounding effects of physical activity and concomitant obesity. Researchers have
shown the linkage between increased sympathetic (Sorof & Daniels, 2002) and reduced
parasympathetic (Gutin et al., 2000) tone to hypertension in obese youth. Similar findings
were reported by Urbina and colleagues (2002), with a trend toward higher sympathetic
and lower parasympathetic measures occurring in adolescent males with diastolic blood
pressure exceeding the 85th percentile. Literary findings in children support the
association between an altered sympathetic-vagal balance and hypertension (Guizar et al.,
2005), but the children in this study who were hypertensive also tended to be overweight
or obese.
Left Ventricular Hypertrophy/Hypertension and QT Interval Duration
QTc Interval prolongation has been identified in children with hypertension
(Kocak, Atalay, Bakkalog, Ekim, & Ayten, 1999) and obese patients (Takebayashi, Aso,
Matsutomo, Wakabayashi & Inukai, 2004). Higher systolic and diastolic blood pressure
measures were associated with longer QTc Interval duration (Takebayashi et al., 2004).

21

In addition, QT peak identified hypertensive patients likely to have LVH (Wong, Lim,
Wong, MacWalter, Struthers, & MacDonald, 2003).
In adults, LVH increased the incidence of QTc Interval prolongation (Kulan, Ural,
Komsuoglu, Agacdiken, Goldeli, & Komsuoglu, 1998). This is theorized to result from
myocardial alterations due to LVH affecting action potential and the duration of
myocardial repolarization, resulting in prolonged QT Interval duration (Kulan et al.,
1998). In a study examining hypertension in adults, no significant differences in QTc
Interval duration or HRV were noted when mild hypertension was present (Franchi et al.,
1996).
It is of great concern that electrocardiograms are not routinely performed on
adolescents. Current indications for obtaining an electrocardiogram in children only
include syncope, exertional symptoms, tachyarrhythmias, bradyarrhythmias, and drug
ingestion (Goodacre & McLeod, 2002). Therefore, it is important that hypertension be
properly diagnosed and treated in children to decrease the risk of QT prolongation and
LVH that may potentially result in sudden cardiac death.
Summary of Studies Examining Left Ventricular Hypertrophy
Obesity and hypertension, even mild untreated hypertension, are associated with
increased risk for LVH. Blacks were more likely than whites to develop LVH, which has
been linked to the higher prevalence of hypertension in blacks than whites. Hypertension
is prevalent among obese youth, increasing their risk for LVH. Prolonged QT Interval has
been identified in children with hypertension and in adults with hypertension and/or left
ventricular hypertrophy. Linkages between HRV and LVH have not been elucidated in
adolescents. Limited research has been conducted in adults examining HRV and LVH
with reduced SDNN measures occurring when hypertension and hypertrophy co-existed.
Studies examining the relationship of HRV to hypertension have yielded equivocal
results, which may be partially attributed to the confounding effects of physical activity
and concomitant obesity.
Impaired Glucose Tolerance in Overweight-Obese Youth
Obesity is linked to the rise in T2DM; nearly half of all adolescents diagnosed
with T2DM are obese (Cruz et al., 2005). Type 2 diabetes is being diagnosed more
frequently in minority adolescents with concomitant obesity (Centers for Disease
Control, 2009). Current recommendations include screening obese children for diabetes
using fasting glucose values, with concomitant insulin levels drawn (Plourde, 2006),
which provide a measure of beta-cell function. Advantages for use of the fasting glucose
for diabetes screening include low cost and convenience. However, in obese adolescents,
single fasting blood glucose may not detect early deterioration in glucose metabolism,
resulting in missed opportunities for intervention (Velasquez-Mieyer et al., 2007).
Fasting blood glucose has been shown to be a poor predictor of diabetes in obese
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adolescents and subjects with polycystic ovarian syndrome (Legro, Kunselman, Dodson,
& Dunaif, 1999). Glucose and insulin indices derived from an oral glucose tolerance test
help evaluate the relationship among adiposity, beta–cell secretory capacity, and insulin
action in those children at higher risk to develop diabetes to determine which treatment
approach is necessary (Velasquez-Mieyer et al., 2007). The American Diabetes
Association (ADA) estimates that 2 million adolescents (17%) have pre-diabetes
(American Diabetes Association, 2008) while others have reported IGT (pre-diabetes) in
up to 25% of obese youth (Plourde, 2006). These numbers may be underestimated, given
that most screenings use fasting values which have been reported to miss between 37 to
66% of overweight adolescents with pre-diabetes, based on oral glucose tolerance test
glucose values (Velasquez-Mieyer et al., 2007). Studies that report higher rates of prediabetes may have included individuals with greater severity of obesity, or investigators
may have used more sensitive measures to assess glucose intolerance. The progression
from pre-diabetes to diabetes is shorter in children than adults (Jolliffe & Janssen, 2006)
and complications may manifest earlier in the disease process.
Glucose Intolerance and Autonomic Dysfunction
While the pathogenesis of diabetic autonomic dysfunction has not been
thoroughly established, it has been postulated that prolonged exposure to metabolic
derangements leads to chronic, widespread neural lesions, with loss of both myelinated
and unmyelinated axons (Greene, Feldman, Stevens, Sima, Albers, & Pfeifer, 1997;
Simmons, 1994; Solders, Persson, & Wilczek, 1986). Accumulation of glucose in nerve
fibers with a slowing of neural conduction, impaired lipid synthesis, and changes in
myelin composition/synthesis may contribute to axon damage (Clarke, Ewing, &
Campbell, 1979; Hoskings, Bennett, & Hampton, 1978).
While autonomic function is adversely affected by chronic elevations in glucose,
conversely autonomic alternations contribute to the development of IGT. Insulin release
is stimulated by parasympathetic activation and sympathetic activation inhibits insulin
secretion (Bloom, Edwards, & Hardy, 1978; McCance & Huether, 2002). Postprandial
insulin hypersecretion has been postulated to be driven by parasympathetic activation of
the pancreatic beta cells through the pancreatic branch of the vagus nerve (Lustig, 2003).
Over time, chronic sympathetic simulation may inhibit insulin secretion from beta cells
(Carnethon et al., 2006), contributing to insulin resistance and IGT.
Glucose Intolerance, Obesity, and Heart Rate Variability
Reports from the Artherosclerosis Risk in Communities Study (Carnethon,
Golden, Folsom, Haskell & Liao, 2003) and the Coronary Artery Risk Development in
Young Adults (CARDIA) study (Carnethon, Jacobs, Sidney, & Liu, 2003) suggest that
changes in autonomic function predict the future development of T2DM. Recently, posthoc analysis of data from the Diabetes Prevention Program (DPP) was conducted to
examine whether autonomic function predicted the development of T2DM in adults with
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IGT, many with concomitant obesity (Carnethon et al., 2006). In this population, there
was no association between baseline HRV measures of sympathetic and parasympathetic
function nor QT Interval measures with the development of T2DM, although baseline
heart rate was modestly related to the development of T2DM across all treatment arms of
the study (Carnethon et al., 2006). However, it is unknown whether these HRV measures,
derived from a single 12-lead EKG, would differ from those seen in obese adults without
IGT. Many uncertainties surround the effects of glucose metabolism on HRV in obese
adolescents; however, HRV changes have been noted in patients with diabetes
(McMillian, 2002).
In adults with T2DM, impaired HRV, with decreased circadian fluctuation, has
been recognized as a risk factor for sudden cardiac death, and autonomic dysfunction
increases, with increased metabolic glucose impairment (Periaccante et al., 2006). Earlier
work by Singh, Larson, O’Donnell, Wilson, Tsuji, Lloyd-Jones, et al., (2000) revealed
that fasting blood glucose levels were inversely correlated with HRV measures of SDNN,
HF, and LF (r = -0.21 to -0.26) although the strength of the association diminished after
adjusting for multiple covariates of age, sex, heart rate, body mass index, antihypertensive and cardiac medications, systolic and diastolic blood pressures, smoking,
and alcohol and coffee consumption. Compared to those with normal fasting glucose
levels, individuals with diabetes and IGT exhibited reduced HRV values for SDNN, LF,
and HF, and LF/HF ratio. After adjusting for the clinical covariates, the impaired glucose
tolerant group continued to have poorer HRV measures compared to the normal glucose
group, although these differences were not statistically significant, while statistically
significant differences in the LF power and LF/HF ratio (measures of sympathetic
function) remained between the normal glucose group and the diabetic group (Singh et al,
2000).
Studies examining differences in autonomic function between adolescents with
type 1 diabetes and those with normal glucose levels support findings from adult studies,
documenting autonomic dysfunction in those with diabetes (Faulkner et al., 2003; Massin
& von Bernuth, 1999; Wawryk, Bates, & Couper, 1997). Even with good metabolic
control, HRV was significantly reduced in children of all ages with type 1 diabetes (ages
3-18, N = 73) (Massin et al., 1999). Impairments in HRV have been reported in children
with T2DM as well. Faulkner et al (2003) reported worse autonomic function in youth
with T2DM compared to those with type 1 diabetes, which may be partially attributed to
the concomitant obesity and lower levels of fitness seen in those with T2DM.
Autonomic neuropathy that occurs in diabetes is neuronal degeneration of
sympathetic and parasympathetic nerve fibers and can manifest early in the development
of diabetes, but it is often difficult to detect during this subtle phase (Varechova, Durdik,
Cervenkova, Ciljakova, Banovcin, & Hanacek, 2007). It is recognized that the pathway to
T2DM involves initial insulin resistance, then IGT, and finally T2DM. While Singh et al
(2000) detected poorer autonomic function in the presence of IGT, numerous co-variates,
including BMI, contributed to these lower values, which could be partially attributed to
greater insulin resistance that is associated with obesity. Severity of insulin resistance is
associated with increasing severity of obesity (McLaughlin, Allison, Abbasi, Lamendola,
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& Reaven, 2004), and greater insulin resistance is associated with more severe
impairment of HRV (Bekezin, Kozlova, Kozlova, & Igolkina, 2008). Thus the decreased
HRV seen in obese youth may partially be attributed to insulin resistance. Whether IGT
in conjunction with obesity provides an additive effect on autonomic dysfunction in
youth has yet to be elucidated.
Glucose Intolerance, Obesity, and QT Interval Duration
There is a paucity of studies examining QT Interval duration and glucose
intolerance. Studies have shown that the occurrence of diabetes is also associated with an
increased prevalence of prolonged QT Interval duration (Brown, Giles, Greenlund, &
Croft, 2001; Girola, Enrini, Garbetta, Tufano, & Cariezel, 2001). A recent study found
that approximately 30% of obese individuals with IGT have prolonged QT Interval
(Poirier, Giles, Bray, Hong, Stern, Pi-Sunyer, et al., 2006). However, information on QT
Interval duration and glucose intolerance in youth is lacking.
Glucose Intolerance, Obesity, and Left Ventricular Hypertrophy
Cardiac diastolic dysfunction may be an early complication of IGT with the
mechanism of its development similar to that seen in diabetes (Fujita, Asanuma, Kim,
Liao, Hirata, Tsukamoto, et al., 2007). In diabetes, hyperglycemia produces advanced
glycation end products that form stable and irreversible cross-links with collagen
polymers in myocardial and arterial walls, decreasing myocardial compensation and
leading to LVH (Fujita et al., 2007). Adult findings have even shown that LVH increased
with increasing glucose intolerance (Lundblad & Eliasson, 2003) and positively
correlated with BMI, age, and blood pressure, as well as fasting blood glucose levels
(Ebinc, Ebinc, Ozkurt, Dogru, & Yilmaz, 2006). Even after adjusting for these covariates, women with deteriorating glucose status had increases in left ventricular mass
(Henry, Kamp, Kostense, Spijkerman, Dekker, van Eijck, et al., 2004). These findings in
adults support the proposition that diabetes and IGT are independent risk factors for LVH
(Fujita et al., 2007). Few studies have examined the relationship of LVH with glucose
intolerance in children. Recently, Khan and colleagues (Khan, Kerr, Ross, Newton, &
Belch, 2006) found that children (n = 21) with even mild glucose intolerance exhibited
arterial stiffening. Within the glucose intolerance group, BMI, BP, and left ventricular
enlargement positively associated (Khan et al, 2006). Additional studies examining the
relationship between glucose intolerance and LVH in youth are needed.
Summary of Glucose Intolerance, Autonomic Dysfunction, and Obesity
Research indicates that diabetes contributes to autonomic dysfunction and that
autonomic alternations precede the development of diabetes. Obesity, insulin resistance,
and mild elevations in glucose levels all contribute to autonomic alternations. Adult
findings support the relationship between diabetes, LVH, prolonged QT Interval, and
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diminished HRV. Findings suggest that glucose intolerance is associated with prolonged
QT Interval in adults. The relationship of glucose intolerance to LVH appears to be
modulated by age, BMI, and blood pressure. Studies examining the effect of glucose
intolerance on HRV have yielded equivocal results. There is a paucity of information
regarding the relationship of IGT to autonomic function in children.
Summary of Review of Literature
Childhood obesity is linked to the development of T2DM and cardiovascular risk
factors, including hypertension. Researchers have suggested that current screening
recommendation for obese youth underestimate risk (Velasquez-Mieyer et al., 2007).
Examination of additional cardiac risk factors, including decreased HRV, QTc
prolongation, and elevated electrographic measures of LVH, which are modulated by
autonomic function, may aid in identifying obese youth at increased risk for these
obesity-associated co-morbidities.
There is a paucity of research examining HRV, QTc duration, and LVH in obese
youth and the relationship of glucose intolerance to these measures. Research findings
suggest that autonomic alternations occur prior to the development of diabetes, with even
mild elevations in glucose levels contributing to deterioration in autonomic function.
Adult studies support the relationship of diabetes and IGT to the development of LVH
and prolonged QTc. However, age, BMI, and BP are co-variants affecting the strength of
the relationships. Mild, non-significant decreases in HRV have been reported in
conjunction with IGT.
Obesity and hypertension, even mild untreated hypertension, are associated with
increased risks for LVH and QT prolongation. Linkages between HRV and LVH have
not been elucidated in adolescents. However, adult studies suggest that lower HRV
measures of parasympathetic function and circadian fluctuation are associated with
longer QT Intervals. Obesity is associated with lower HRV measures of sympathetic and
parasympathetic function, with duration of obesity affecting relationships between
obesity and sympathetic function. Further examination of these factors in overweight and
obese adolescents is vital, given the linkage of impaired autonomic function to sudden
cardiac death.
Studies suggest that blacks have a higher prevalence of LVH and greater disease
burden. Contradictory findings on racial differences in HRV measures and QT Interval
duration have been reported; thus further investigation in this area is warranted.
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CHAPTER 3. METHODS
This study was undertaken to explore relationships between cardiac risk factors of
HRV, QTc duration, and electrical voltage criteria for LVH to BMI, RBMI, and blood
pressure measures in overweight-obese adolescents. Additionally, this study examined
the effects of glucose tolerance, hypertension, and race on HRV, QTc Interval duration,
and electrical voltage measures for LVH in this population. The methodology section will
provide a description of the study design, setting, sample, instruments, procedures,
statistical analysis used to address aims and hypotheses in this study. A description of the
approaches used to ensure the protection of human subjects is also provided.
Research Design
The study design was a cross-sectional, correlational secondary analysis of data.
Data were obtained from overweight-obese adolescents age 11-18 years (N = 128). The
overweight-obese youth that participated in this study were part of a larger study
designed to investigate potential racial differences associated with IGT in overweightobese youth. The secondary correlational study design was used to study HRV, QTc
Interval duration, and electrical voltage measures for LVH differences between
adolescent groups with regards to glucose tolerance, hypertension, and race. Descriptive
statistics were used to examine the sample characteristics. Through the use of
correlation, the researcher was able to understand the relationship between HRV, QTc
duration, and electrical voltage measures for LVH in relation to BMI, RBMI, and blood
pressure measures. Independent samples t-tests were used to compare glucose tolerance,
hypertension, and race in overweight-obese adolescents for cardiovascular risk factors of
HRV, QTc duration, and electrical voltage measures for LVH.
Sample and Setting
The initial sample was recruited from a large metropolitan city in the mid-south
region of the United States. A total of 188 charts were reviewed and from the original
sample (N = 128) overweight-obese youth who were aged 11-18 years were included in
the study sample. Participants were included in this study that had completed data and
analyzable ECG at rest and 24-hour Holter monitor recordings. Electrocardiograms and
24-hour Holter recordings that could not be accurately measured and interpreted were
excluded, due to the inability to measure accurately and interpret HRV, QTc duration,
and electrical voltage for LVH based upon study criteria in this sample of overweightobese youth.
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Inclusion Criteria
Participants included in the original study were either black or white youth
ranging from 11-18 years of age who were overweight or obese. They had no previous
diagnosis of diabetes, nor were they taking medications that could affect glucose
metabolism or autonomic function. Parents and/or legal guardians signed informed
consent and assent was provided by the youth.
For this secondary data analysis, additional inclusion criteria included:
•
•
•
•

Age 11-18 years.
Anthropometrics data available for analysis.
Analyzable 12-lead electrocardiogram.
24-hour Holter recordings, with at least 18 hours of analyzable data available for
interpretation.
• Fasting glucose and 2-hour post load values from the oral glucose tolerance test or
mixed meal tolerance test available.
Exclusion Criteria
Exclusion criteria for the current study included:
• Participants younger than 11 or older than 18 years of age at the time the data
were collected for the original study.
• Participants that had incomplete data of any of the following measures:
anthropometrics, 24-hour Holter monitor, 12-lead electrocardiogram, or oral
glucose/mixed meal tolerance test.
• Electrocardiogram or Holter recordings unable to be accurately measured and
analyzed according to study criteria.
• Individuals diagnosed with diabetes during the original study.
Sample Description
The sample consisted of overweight-obese youth age 11-18 years (N = 128). Of
the participants included in this study, 51 were whites (39.8%) and 77 were black
(60.2%). The average age of the sample was 14.32 years, with 63.3% female and 36.7%
male. Six (4.7%) were overweight and 122 (95.3%) were obese. Thirty-six (28.1%) of
participants were classified as having IGT, and ninety-two (71.9%) were classified as
having normal glucose tolerance.
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Instrumentation
Body Mass Index and Relative Body Mass Index
Calculation of BMI was obtained from measurements of height and weight
obtained from each participant. During the original study, height was measured on
participants without shoes, and weight was measured using a calibrated scale without
shoes and excessive clothing. Body mass index was used to classify youth as overweight
or obese in kg/m2 according to age and gender percentiles. Relative body mass index was
used to determine severity of obesity and was calculated using the following equation:
(RBMI) [BMI/ (BMI50th percentile for age and sex * 100)].
Oral Glucose and Mixed Meal Tolerance Test
Glucose tolerance status was determined from data collected during the original
study from the 2-hour oral glucose tolerance test or mixed meal tolerance test. The most
common method for determining IGT in adolescents is the oral glucose tolerance test
(OGTT) (American Diabetes Association, 2008). During the OGTT, dextrose [(1.75
grams/kg) (maximum 75 grams)] is ingested orally and blood samples were obtained
prior to administration of dextrose at 30, 60, 90, and 120 minutes (Barker, McFann, &
Orban, 2007). Another method commonly used is the mixed meal tolerance test
(MMTT). During the MMTT fasting, subjects ingest a liquid meal and over 2-4 hours Cpeptide levels are measured at timed Intervals (Greenbaum, Mandrup-Poulsen, McGee,
Battelino, Haastert, Ludvigsson, et al., 2008). Both tests measure “insulin action, B-cell
function, and the rate of meal glucose appearance” (Dalla Man, Campioni, Polonsky,
Basu, Rizza, Toffolo, et al., 2005, p#. 3265). Findings have also indicated a significant
correlation between the MMTT and the OGTT (Marena, Montegrosso, De Michieli, Pisu,
& Pagano, 1992).
Following a 10-hour overnight fast, a 2-hour OGTT or MMTT was performed.
For completion of the OGTT, one gram of dextrose/kg of body weight up to 75 grams
was consumed, and blood samples were obtained at 0, 15, 30, 60, 90, and 120 minutes
during the original study. For the MMTT a liquid meal was ingested (Sustacal/Boost) (6
kcal/kg, body weight, max 360 kcal) and blood samples were obtained at 0, 15, 30, 60, 90
and 120 minutes during the original study. Impaired glucose tolerance was determined
using the American Diabetes Association 2008 guidelines. Impaired glucose tolerance
was determined if participants had a fasting glucose level of 100-126 mg/dl or a 2-hour
plasma glucose level between 140-200 mg/dl.
Systolic/Diastolic Blood Pressure
A resting blood pressure was obtained with a sphygmomanometer and appropriate
size cuff. Normative blood pressure tables developed by the National High Blood
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Pressure Education Program Working Group on High Blood Pressure in Children and
Adolescents were utilized for single blood pressure readings rather than multiple
readings. These guidelines have recently incorporated the pre-hypertensive category
(McNiece et al., 2007). A SBP or DBP > 95th percentile was considered hypertension,
Pre-hypertension was categorized as having a systolic/diastolic blood pressure > 90th but
less than the 95th percentile, and non-hypertensive is a systolic/diastolic blood pressure <
90th percentile for age, height, and sex (McNiece et al., 2007). Pre-hypertension is a
fairly new classification for blood pressure (American Heart Association, 2009), but
studies conducted have identified that pre-hypertension is linked to increased
cardiovascular risk (Qureshi, Suri, Kirmani, Divani, & Mohammad, 2005; American
Heart Association, 2009). Pre-hypertensive or hypertensive youth have an increased
incidence of alterations in cardiac structure, which includes the presence of LVH,
compared to youth with normal blood pressures. This suggests that pre-hypertension has
a profound effect on cardiovascular risk, similar to that seen in hypertension. Therefore,
pre-hypertensive adolescents were grouped with hypertensive adolescents to form the
elevated blood pressure group and subject groups consisted of those identified to have
elevated blood pressure or as non-hypertensive.
Ambulatory Electrocardiogram Analysis and Editing
Marquette Electronics version 5.8 Ambulatory Electrocardiogram Analysis and
Editing System was utilized for editing and analysis of Holter recorded data for HRV.
During the initial study, subjects participated in normal activities and were advised not to
expose the Holter monitor to water while documenting sleep, exercise, or unusual stress.
Following the conclusion of the 24-hour period, subjects removed the Holter monitor.
Recordings were scanned into the Multi-parameter Arrhythmia Review Station (MARS)
PC Analysis and Editing system (GE Marquette Medical Systems, Milwaukee, WI, USA)
version 5.8, and QRS complexes were digitally processed and assigned a template for
manual validation and over reading. Following validation, HRV was performed using the
computerized system according to the manufacturer settings.
The power spectral density technique was used in this study to separate frequency
waveforms into low (0.04-0.15 Hertz), high (0.15-0.40 Hertz), and total frequency (0.11.0 Hertz) components. The low frequency component is representative of sympathetic
and parasympathetic function. The high frequency component reflects parasympathetic
function, and the total frequency component reflects R-R interval variability. 24-hour
measures of high frequency components and time domain measures of SDNN were
utilized in the analysis of HRV data, with each recording containing at least 18 hours of
analyzable data.
12-lead Electrocardiogram
A 12-lead electrocardiogram was conducted on all participants at rest during the
original study to determine QTc duration and Cornell voltage measures for LVH. A
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researcher trained in electrocardiogram rhythm analysis manually measured the available
data, and measures were initially reviewed and validated by a skilled Pediatric
Cardiologist, to ensure accuracy and consistency. The 12-lead electrocardiogram was
conducted at a standard paper speed of 25 mm/sec.
The QT Interval was measured from the beginning of the QRS complex to the end
deflection of the T wave. By dividing the square root of the preceding R-R interval of
each QT Interval in the tracing, the three distinct, corrected QT Intervals (QTc) were
determined according to Bazett’s formula, correcting for variations in heart rate. After the
QT Interval and the preceding RR interval were examined in three consecutive
waveforms and corrected individually in lead II of the 12-lead electrocardiogram, the
average of the three QTc calculations were used to determine the QTc within the
electrocardiogram tracing for data purposes. The QTc Interval was considered prolonged
if > 0.425 sec in adolescent males and females aged 11-18 years.
Left ventricular hypertrophy was determined in the overweight and obese youth
using the Cornell Voltage Criteria by measuring the S wave in lead V3 + R wave in lead
aVL. In obese individuals, electrical forces within the heart become more posterior, and
the SV3 is the most representative voltage for evaluating posterior electrical forces (Eckel,
2003). When LVH is present in obese individuals, the heart is shifted more horizontally
in the chest cavity, which explicates the importance of the RaVL (Eckel, 2003). These
measurements are for the Cornell criteria.
The R wave was measured as the first positive deflection in the QRS complex,
following the Q wave and arising from ventricular activation. The S wave was measured
as the negative deflection following the R wave in the QRS complex. The normal S
wave in lead V3 and R wave in aVL have yet to be identified for adolescents for use
when overweight-obesity is present, but according to adult criteria in obese adults LVH is
considered to be present in males if SV3 + RaVL is > 2.8 mV and in females > 2.0 mV.
Cornell voltage criteria have not yet been used in overweight-obese youth, and adult
criteria were used to determine the presence LVH in overweight-obese youth (see Table
3-1).
Procedures
Institutional Review Board (IRB) approval was obtained from The University of
Tennessee Health Science Center to conduct this study. In addition, prior written consent
was obtained from parents or legal guardians and assent from youth prior to enrollment in
the original study.
Selection of Participants
Based on the information provided in the larger study (N = 128), participants were
selected. Consent forms from the larger study were reviewed. Also, the principle
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Table 3-1. Variables and Measurements.
Variable

Measurement

Demographic Data

Age, Gender, & Race.

Overweight-Obese

Body mass index ≥ 85th overweight or ≥ 95th obese for age
and gender percentiles.

Severity of Obesity

Relative body mass index
BMI / (BMI50th percentile for age and sex * 100).

Glucose Tolerance

Oral glucose or mixed meal tolerance test, IGT = FG 100126 mg/dl or 2-hour post load between 140-200 mg/dl.

Elevated BP

Systolic and diastolic BP measures ≥ 90th percentile for age
and gender = elevated BP.

Heart Rate Variability

24-hour measures of SDNN (circadian fluctuation) and high
frequency (parasympathetic function).

QT Interval duration

12-Lead ECG (QTc = QT / √ RR) > 0.425 sec = prolonged.

Cornell Voltage for
LVH

12-Lead ECG (S wave in V3 + R wave in aVL) > 2.8 mV in
males or > 2.0 mV females = LVH.

Note. IGT = Impaired Glucose Tolerance; FG = Fasting Glucose; BP = Blood Pressure;
ECG = Electrocardiogram; LVH = Left Ventricular Hypertrophy.
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investigator in the current study was given access to Holter recording data through the
MARS PC Workstation for HRV analysis, 12-lead electrocardiogram reports for analysis
of QTc duration and LVH, and also access to de-identified data from the larger study,
including oral glucose tolerance status and anthropometrics for calculation of BMI.
Holter recording analysis and electrocardiogram analysis data were matched to the initial
subject using the code assigned to the participant. The current study included (N = 128)
overweight-obese youth that did not have missing or incomplete data. Data collection for
the larger study occurred in a large metropolitan city in the mid-south region of the
United States.
Data Analysis
Data analysis was conducted using Statistical Software for the Social Sciences
(SPSS) software version 15.0. Data were entered into an Excel spreadsheet; de-identified
and codes were used to maintain confidentiality and anonymity. The data were
subsequently imported to SPSS v. 15.0 for data analysis. Frequency distributions were
obtained for categorical data such as race, gender, age, hypertensive status, and glucose
tolerance. Descriptive statistics were performed to describe and characterize the sample
of overweight-obese adolescents. Pearsons Correlation Coefficients were estimated to
examine relationships between variables. Statistical tests included independent samples
t-tests and chi-square analysis. The a priori significance level was set at 0.05 for all
research aims.
Following a description and characterization of overweight-obese adolescents aims of
this study:
(1) Examined the relationship between HRV, QTc Interval duration, and electrical
voltage measures for LVH to BMI, RBMI, and systolic/diastolic blood pressure
measures in overweight-obese adolescents.
Hypothesis: It was hypothesized that BMI, RBMI, and increased
systolic/diastolic blood pressure measures would be associated with lower HRV,
more prolonged QTc duration, and higher measures of electrical voltage for LVH.
To address this aim, Pearson’s Product Moment Correlation Coefficients were
used to examine relationships between the variables.
(2) Compared HRV, QTc Interval duration, and electrical voltage measures for LVH
in overweight-obese adolescents with and without IGT.
Hypotheses: Overweight-obese adolescents with IGT would exhibit lower HRV,
more prolonged QTc Interval, and higher electrical voltage measures for LVH
compared to overweight-obese adolescents with normal glucose tolerance.
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To address aim two; Levene’s test of homogeneity of variance was used to meet
the assumption of equal variances. For variables that met the condition of equal
variances, independent samples t-test was used to determine differences in
overweight-obese adolescents with and without IGT.
(3) Compared HRV, QTc Interval duration, and electrical voltage measures for LVH
in overweight-obese adolescents with elevated blood pressure and nonhypertension.
Hypotheses: Overweight-obese adolescents with elevated blood pressure would
exhibit lower HRV, more prolonged QTc Interval, and higher electrical voltage
measures for LVH compared to overweight-obese adolescents with nonhypertension.
To address aim three Levene’s test of homogeneity of variance was used to meet
the assumption of equal variances. For variables that met the condition of equal
variances, independent sample t-test was used to determine differences in
overweight-obese adolescents with elevated blood pressure and non-hypertension.
Chi-square analysis was used to evaluate differences in frequency of elevated
blood pressure distributions between glucose tolerance groups.
(4) Compared HRV, QTc Interval, and electrical voltage measures for LVH in black
and white overweight-obese adolescents.
Hypotheses: Black overweight-obese adolescents will display lower HRV, more
prolonged QTc Interval, and higher electrical voltage measures for LVH than
their white peers.
To address aim four; Levene’s test of homogeneity of variance was used to meet
the assumption of equal variances. For variables that met the condition of equal
variances, independent samples t-test was used to determine differences in black
vs. white overweight-obese adolescents in relation to HRV, QTc duration, and
electrical voltage measurements for LVH. Chi-square analysis was used to
evaluate differences in frequency distributions between racial groups for glucose
tolerance.
Protection of Human Subjects
The original and current study received Institutional Review Board approval from
the University. Written and verbal consent and assent was received from parents/legal
guardians and participants respectively during the original study, and the principle
investigator maintained each participant’s confidentiality and anonymity. Files containing
participant data from the original study were kept in a locked file cabinet in a health
clinic and only IRB approved study personnel were allowed access, and the data were deidentified with codes, and the codes were used to match Holter and electrocardiograms to
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the appropriate participant. Risks to study participants that were identified in the original
study included weakness and fatigue due to the fasting state necessary for the OGTT and
MMTT. In addition venipuncture during the OGTT and MMTT could have caused pain,
excessive bleeding, or increased risk for infection at the insertion site due to a break in
the skin’s natural integrity. The sites of electrode placement for the electrocardiogram or
Holter monitor could also lead to skin irritation. Although minimal risks were involved in
the initial study they were outweighed by the expected benefits gained as a result of
conducting the study. During the current study of previously collected data there were no
risks involved, with the exception of the risk for a breach in patient confidentiality.
Therefore, all data were kept confidential and coded to maintain the participants’
anonymity.

35

CHAPTER 4. RESULTS
Introduction
The purpose of this study was to examine relationships for HRV, QTc duration,
and electrical voltage measures for LVH to BMI, RBMI, and blood pressure measures in
overweight-obese adolescents. In addition, this study sought to determine the effects of
glucose tolerance, hypertension, and race on HRV, QTc Interval duration, and electrical
voltage criteria for LVH in overweight-obese adolescents. The results from this study
may provide additional risk stratification in adolescents by identifying whether
overweight-obesity with concomitant glucose intolerance, hypertension, and/or race
adversely affects HRV, QTc duration, and/or electrical voltage measures for LVH,
compounding cardiovascular risks. This chapter provides a description of sample
characteristics in addition to an analysis of results to research aims.
Description of the Sample
The sample consisted of (N = 128) overweight-obese adolescents age 11-18 years
that were initially part of a larger study. All of the study participants were overweightobese according to the Centers for Disease Control, based on age, height, and gender
percentiles. Study participants had primarily been recruited from an obesity-diabetes
specialty clinic located in a large metropolitan city within the mid-south region of the
United States. This clinic serves as a referral clinic for adolescents within a 250-mile
radius. Additionally, participants were recruited through flyers at area family practice
clinics. A total of 188 charts were reviewed to determine eligibility for this secondary
data analysis. Of these 188 records, 128 met all inclusion criteria and had complete data
sets available for analysis. Participants included in this study consisted of 51 whites
(39.8%) and 77 blacks (60.2%), of which the majority was female (63.3%). Six
adolescents (4.7%) were overweight and 122 (95.3%) were obese. Table 4-1 summarizes
the descriptive characteristics of the entire sample.
Glucose tolerance and blood pressure status were obtained for the total group. In
addition, cardiac risk factors of HRV, QTc duration, and electrocardiographic voltage
measures for LVH (Cornell Criteria) were obtained. Elevations in systolic blood pressure
were more common than elevations in diastolic blood pressure (51.5% vs. 0.09%), with
diastolic hypertension always occurring in the presence of systolic hypertension. Table 42 summarizes the mean values for each of the variables.

Aim One
Aim one examined relationships between HRV, QTc Interval duration, and
Cornell electrical voltage measures for LVH to BMI, RBMI, and systolic/diastolic blood
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Table 4-1. Characteristics of Study Participants.
Characteristic

Total Group
(N=128)

Age (years; mean ± SD)

14.32 ± 1.91

Body Mass Index

37.18 ± 7.40

Relative Body Mass Index

188.22 ± 34.76

Race (% Black)

60.1

Gender (% F)

63.2

Note. F = Female.
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Table 4-2. Cardiac Risks in Overweight-Obese Adolescents.
Characteristic

Total Group

Systolic BP (mm/Hg; mean ± SD)

123.63 ± 13.31

Diastolic BP (mm/Hg; mean ± SD)

69.47 ± 8.36

Elevated BP (%)

51.5

IGT (%)

28.1

High Frequency (ms2 ; mean ± SD)

6.23 ± 1.86

SDNN (ms; mean ± SD)

138.94 ± 39.67

Average QTc duration (sec; mean ± SD)

0.408 ± 0.350
34.3

QTc Prolonged (%)
Cornell Voltage Criteria
(mV; mean ± SD)

0.86 ± 0.35

Note. BP = Blood Pressure; IGT = Impaired Glucose Tolerance; SDNN = Standard
deviation of all normal RR intervals.
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pressure measures in overweight-obese adolescents. Specifically it is also hypothesized
that BMI, RBMI, and increased systolic/diastolic blood pressure measures will be
associated with lower high frequency and SDNN measures of HRV, more prolonged QTc
duration, and higher measures of electrical voltage for LVH. Pearson’s Product Moment
Correlation Coefficients were used to examine relationships between the variables, with
an alpha level of 0.05 set for statistical significance.
The relationships between HRV, QTc Interval duration, and electrical voltage
measures for LVH to BMI, RBMI, and blood pressure were explored using correlational
analysis. BMI was not significantly correlated with high frequency or SDNN measures of
HRV, QTc Interval duration, or Cornell voltage measures for LVH. Relative body mass
index was not significantly correlated with high frequency or SDNN (circadian
fluctuation) HRV measures, QTc Interval duration, or Cornell voltage measures for LVH.
Systolic blood pressure measures modestly correlated with Cornell voltage measures (r =
0.231, p = 0.009) but not with high frequency, SDNN, or QTc Interval duration. Diastolic
blood pressure measures did not correlate with high frequency or SDNN measures of
HRV, QTc Interval duration, or Cornell voltage measures.
In summary, higher systolic blood pressure measures were modestly correlated to
Cornell voltage measures for LVH. Table 4-3 displays the Pearson Product Moment
Correlational Coefficients between the cardiac risk factors.
Aim Two
Aim two examined the effect of glucose tolerance on HRV, QTc Interval
duration, and measures of electrical voltage for LVH in overweight-obese adolescents.
Subjects were grouped, based upon glucose tolerance status, as either having IGT (fasting
blood glucose ≥ 100 and < 126 mg/dl or 2-hr post-load glucose ≥ 140 and < 200 mg/dl)
or normal glucose tolerance (fasting glucose < 100 mg/dl or 2-hr post-prandial glucose <
140 mg/dl). Chi-square analysis and independent samples t-tests were performed to
examine whether the characteristics of the two groups differed. The two groups were
similar in age, gender, race, and severity of obesity (p = NS for all comparisons; see
Table 4-4). Independent samples t-tests were used to compare HRV measures, QTc
duration, and Cornell voltage for LVH between glucose tolerance groups. Differences in
the frequency of elevated blood pressure between the glucose tolerance groups were
examined using Chi-square analysis. An alpha level of 0.05 was significance a priori.
There were no significant differences in HRV (HF, p = 0.25; SDNN, p = 0.108),
QTc duration (p = 0.59), or Cornell voltage (p = 0.33) between the IGT and NGT groups
(see Table 4-5). In addition the IGT group had a slightly higher frequency of elevated
blood pressure than the NGT group, though not statistically significant (64% vs. 47%, χ =
3.047, p = 0.08).
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Table 4-3. Correlations between Cardiac Risks in Overweight-Obese Adolescents.
Variable

HF

SDNN

QTc

Cornell
Voltage

BMI
r=
p=

-0.077
0.385

-0.075
0.400

0.065
0.465

0.004
0.968

RBMI
r=
p=

-0.028
0.750

-0.121
0.173

0.087
0.331

-0.026
0.767

SBP
r=
p=

0.056
0.532

0.080
0.371

0.061
0.495

0.231
0.009*

DBP
r=
p=

0.078
0.380

-0.136
0.125

0.171
0.053

0.031
0.726

Note. HF = High Frequency; SDNN = Standard Deviation of all normal RR intervals;
Cornell Voltage = S wave in V3 + R wave in AvL; BMI = Body Mass Index; RBMI =
Relative Body Mass Index; SBP = Systolic Blood Pressure; DBP = Diastolic Blood
Pressure; *p ≤ 0.05.
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Table 4-4. Characteristics of Study Participants Based on Glucose Status.
Variable

IGT
(n = 36)

NGT
(n = 92)

Age (years; mean ± SD)

14.11 ± 1.89

14.40 ± 1.93

Body Mass Index

36.62 ± 6.47

37.40 ± 7.76

186.33 ± 29.51

188.95 ± 36.73

Race (% Black)

61.1

59.7

Gender (% F)

63.8

63.0

Relative Body Mass Index

Note. IGT = Impaired Glucose Tolerance; NGT = Normal Glucose Tolerance; F =
Female; P = NS between groups for all measures.
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Table 4-5. Cardiac Risks in Study Participants Based on Glucose Status.
Variable

IGT
(n = 36)

NGT
(n = 92)

Systolic BP (mm/Hg; mean ± SD)

125.47 ± 14.09

122.90 ± 12.99

Diastolic BP (mm/Hg; mean ± SD)

70.06 ± 7.19

69.24 ± 8.80

63.8

46.7

6.60 ± 4.09

6.08 ± 0.90

SDNN (ms; mean ± SD)

130.75 ± 32.94

142.14 ± 41.73

Average QTc duration (sec; mean ±
SD)

0.411 ± 0.029

0.407 ± 0.036

38.8

32.6

0.91 ± 0.33

0.84 ± 0.36

Elevated BP (%)
High Frequency (ms2 ; mean ± SD)

QTc Prolonged
Cornell Voltage Criteria
(mV; mean ± SD)

Note. IGT = Impaired Glucose Tolerance; NGT = Normal Glucose Tolerance; BP =
Blood Pressure; SDNN = Standard deviation of all normal RR intervals; P=NS between
groups for all measures.
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Aim Three
Aim three examined differences in HRV, QTc Interval duration, and Cornell
voltage measures for LVH in overweight-obese youth with and without elevated blood
pressure. Subjects were initially grouped based upon blood pressure status as prehypertensive, hypertensive, or non-hypertensive. Frequency tables were prepared which
indicated 39.8% hypertensive, 11.7% pre-hypertensive, and 48.4% non-hypertensive.
Studies suggest that cardiovascular risk associated with pre-hypertension is similar to that
identified in hypertension (American Heart Association, 2009; Qureshi et al., 2005),
therefore, pre-hypertensive and hypertensive subjects were grouped to form the elevated
blood pressure category. Independent samples t-tests were used to compare elevated
blood pressure and non-hypertensive groups based upon HRV measures, QTc duration,
and Cornell voltage measures (see Table 4-6).
There was no significant difference in parasympathetic function (HF, p = 0.31),
SDNN (p = 0.80), and QTc (p = 0.92) between the blood pressure groups. Subjects with
elevated blood pressure displayed significantly higher measures of Cornell Voltage for
LVH (0.95 mV vs. 0.76 mV, p = 0.004) than those overweight-obese youth with normal
blood pressure measures (see Table 4-7).
Aim Four
Minorities experience a considerable disease burden engendered by overweightobesity (Department of Health and Human Services, 2003). Aim 4 examined whether
black overweight-obese youth exhibited lower HRV, more prolonged QTc duration, and
higher Cornell voltage measures for LVH than their white peers. Subjects were grouped
based upon self-reported race as either black or white. Independent samples t-test was
used to compare groups for HRV, QTc duration, and Cornell voltage measures for LVH.
Chi-square analysis was used to evaluate racial differences in frequency distributions of
glucose tolerance (see Table 4-8).
There was no significant difference between racial groups for high frequency (p =
0.106), QTc (p = 0.599), or Cornell voltage for LVH (p = 0.965). Black adolescents had a
significantly lower SDNN (circadian fluctuation), than white peers (p = 0.000; see Table
4-9). In addition, overweight-obese black adolescents had a similar frequency of IGT as
white peers, (28.57% vs. 27.45%, χ = 0.01, p = 0.890).
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Table 4-6. Characteristics of Study Participants Based on Blood Pressure Status.
Variable

Elevated BP
(n = 66)

Non-Hypertension
(n = 62)

Age (years; mean ± SD)

14.45 ± 0.21

14.18 ± 0.26

Body Mass Index

38.72 ± 0.87

35.54 ± 0.93

Relative Body Mass Index

194.88 ± 3.97

181.12 ± 4.52

Race (% Black)

60.6

59.6

Gender (% F)

56.1

70.9

Note. BP = Blood Pressure; F = Female; P = NS between groups for all measures.
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Table 4-7. Cardiac Risks in Study Participants Based on Blood Pressure Status.
Variable

Elevated BP
(n = 66)

Non-Hypertension
(n = 62)

Systolic BP (mm/Hg; mean ± SD)

133.23 ± 9.40

113.40 ± 8.26

Diastolic BP (mm/Hg; mean ± SD)

71.91 ± 8.24

66.87 ± 7.73

34.8

20.9

6.42 ± 3.06

6.01 ± 0.91

SDNN (ms; mean ± SD)

139.82 ± 40.30

138.00 ± 39.28

Average QTc Duration (sec; mean ± SD)

0.408 ± 0.033

0.408 ± 0.037

33.3

35.4

0.95 ± 0.36*

0.76 ± 0.31

IGT (%)
High Frequency (ms2 ; mean ± SD)

QTc Prolonged (%)
Cornell Voltage Criteria
(mV; mean ± SD)

Note. BP = Blood Pressure; IGT = Impaired Glucose Tolerance; SDNN = Standard
deviation of all normal RR intervals; *p ≤ 0.05.
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Table 4-8. Characteristics of Study Participants Based on Race.
Variable

Blacks
(n = 77)

Whites
(n = 51)

Age (years; mean ± SD)

14.22 ± 1.95

14.77 ± 1.86

Body Mass Index

37.56 ± 8.06

36.61 ± 6.32

190.36 ± 37.80

184.98 ± 29.64

71.4

50.9

Relative Body Mass Index
Gender (% F)

Note. F = Female; P = NS between groups for all measures.
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Table 4-9. Cardiac Risks in Study Participants Based on Race.
Variable

Blacks

Whites

Systolic BP (mm/Hg; mean ± SD)

123.65 ± 14.06

123.59 ± 12.20

Diastolic BP (mm/Hg; mean ± SD)

70.61 ± 8.75

67.75 ± 7.49

Elevated BP (%)

51.9

50.9

IGT (%)

28.5

27.4

5.96 ± 0.89

6.63 ± 3.44

128.62 ± 35.16*

154.51 ± 41.30

0.407 ± 0.384

0.410 ± 0.029

32.4

37.2

0.86 ± 0.33

0.86 ± 0.38

High Frequency (ms2 ; mean ± SD)
SDNN (ms; mean ± SD)
Average QTc duration (sec; mean ± SD)
QTc Prolonged (%)
Cornell Voltage Criteria (mV; mean ± SD)

Note. BP = Blood Pressure; IGT = Impaired Glucose Tolerance; SDNN = Standard
deviation of all normal RR intervals; *p ≤ 0.05.
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CHAPTER 5. DISCUSSION, IMPLICATIONS, AND CONCLUSIONS
This study investigated the effects of glucose tolerance, hypertension, and race on
HRV, QTc Interval duration, and measures of Cornell voltage for LVH in overweightobese adolescents. This chapter presents a discussion of the study findings and explores
the relationship of these findings to practice, theory, and other research findings.
The sample consisted of 128 overweight-obese adolescents with an average age of
14.32 years of age. The majority of the participants were obese black females. A high
prevalence of pre-diabetes in obese children and adolescents has been reported (Rodbard,
2008), and this study further supports this finding. Twenty-eight percent of overweightobese youth within this study had IGT, which is slightly higher than results noted within
the literature that state 25% of obese youth have IGT (Plourde, 2006). Pletcher and
colleagues (2008) reported that in young adults pre-hypertension is more common in
blacks than whites. Within our study both black and white youth were just as likely to
have elevated blood pressure (50% vs. 51%), respectively, in the presence of overweightobesity.
Aim One
Aim one examined the relationship between cardiac risk factors of HRV, QTc
Interval duration, and Cornell voltage measures for LVH to BMI, RBMI, and systolic and
diastolic blood pressure measures in overweight-obese adolescents.
Study findings indicated BMI, RBMI, and diastolic blood pressure measures did
not correlate with HF and SDNN measures of HRV, QTc Interval, or Cornell voltage
measures. Systolic blood pressure did not correlate with HF and SDNN measures of
HRV and QTc Interval, but was significantly correlated with Cornell voltage measures.
Divergent findings have been reported for HF and SDNN measures of HRV and
QT Interval duration when obesity is present. Researchers acknowledge overall HRV
measures are not decreased in obese youth (Martini et al., 2001), and further
investigations reported obese youth have slightly lower HF measures (Martini et al.,
2001), while decreased SDNN is reported in individuals with T2DM (Periaccante et al.,
2006). Contrary findings have been reported regarding the relationship of obesity to QT
Interval duration in adults. While several studies indicated that obesity might lead to QT
prolongation (El Gamal et al., 1995; Poirier et al., 2006), another found no correlation
existed between QT duration and BMI (Girola et al., 2001).
Cornell voltage measures within our study did not suggest that LVH was present
in any adolescent in this study, based upon the adult standard. An adult standard was
used because normative standards in overweight-obese adolescents using Cornell criteria
have not yet been established. The lack of variability of Cornell voltage measures in
overweight-obese youth and no identified LVH in subjects may have contributed to the
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lack of correlation identified between BMI, RBMI, and Cornell voltage measures for
LVH.
A modest correlation was identified for systolic blood pressure and Cornell
voltage measures. This is not surprising because the most common cause of LVH is
hypertension (Edhouse et al., 2002) and even mild hypertension in youth is shown to
correlate with LVH (Ippisch & Daniels, 2008). No correlation was identified for systolic
and diastolic blood pressure for HRV measures of HF and SDNN, and QTc duration.
Literature reports when hypertension is present, SDNN measures of HRV are reduced
(Alter et al., 2006) and when mild hypertension is present there may be no difference
identified in HRV measures (Franchi et al., 1996). In this group of overweight-obese
youth, HF measures and SDNN measures of HRV are not correlated with blood pressure
measures. Faulkner and colleagues (2005) reported age and gender variations in HRV
measures, and females are reported to have lower HRV values than males. This sample
contained slightly more females, which could have influenced study findings.
Prolongation of the QTc Interval has been identified to be associated with hypertension in
children (Kocak et al., 1999), but similar to HRV measures it has been reported that no
difference in QT duration may present when hypertension is mild (Franchi et al., 1996).
Obesity is associated with cardiac autonomic dysfunction (Gutin, Howe, Johnson,
Humphries, Snieder, & Barbeau, 2005), QTc duration (Poirier et al., 2006), and LVH
(Vasan, 2003) in adult subjects. However, overall lack of correlation identified for BMI
and RBMI to HRV, QTc duration, and Cornell voltage in this study could be related to
the overall marked elevation of BMI and RBMI throughout the entire sample. The
inclusion or a more varied weight group and/or healthy weight adolescents would be
beneficial for future investigation.
Aim Two
Aim two examined differences between glucose tolerance groups for the
dependent variables; HRV, QTc duration, and Cornell voltage criteria for LVH in
overweight-obese adolescents. It has been noted that diabetes is linked to diminished
HRV (Periaccante et al., 2006), prolonged QTc duration (Vinod Porwal, 2005), and the
presence of LVH (Foppa, Duncan, Arnett, Benjamin, Liebson, Manolio, & Skelton,
2006). Therefore, it was important to investigate if this link also existed for pre-diabetes
amongst these variables in overweight-obese adolescents. Although HRV measure of
SDNN was slightly decreased, QTc duration slightly prolonged, and Cornell voltage
measures for LVH were slightly increased in the impaired glucose tolerant group, these
values were not significantly different from the normal glucose tolerant group.
Research in adults suggests a weak relationship between pre-diabetes and HRV
measures (Schroeder, Chambless, Liao, Prineas, Evans, Rosamond, et al., 2005), which is
consistent with findings from this current study. In adults with T2DM, HRV measures of
SDNN are decreased (Periaccante et al., 2006); however, although SDNN is slightly
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decreased in this sample of overweight-obese adolescents, no statistically significant
difference was noted.
In adolescents, a QTc Interval > 0.425 sec is considered prolonged, and in this
study 38% of overweight-obese adolescents with IGT had QTc Interval prolongation. A
study in adults report approximately 30% of obese individuals with IGT have QTc
prolongation (Poirier et al., 2006). Similar findings were noted in this study of
overweight-obese adolescents; of those adolescents with IGT, 38% had QTc Interval
prolongation, which is slightly more than that identified in adults. Obesity may be one of
the most common causes of prolonged QTc Interval duration (El Gamal et al., 1995). In
this study of overweight-obese adolescents, 34% of total participants were considered to
have prolonged QTc Interval duration. These findings may simply suggest that obesity
throughout both impaired and normal glucose tolerance groups played a more essential
role in QTc Interval duration than glucose tolerance alone.
Literature suggests that diastolic dysfunction may be an early complication of
IGT (Fujita et al., 2007), and LVH has been shown to increase with increasing glucose
intolerance. No significant difference was noted between overweight-obese adolescents
with or without IGT for Cornell voltage measures for LVH. Although IGT was identified
in study participants within this sample, its degree and duration is unknown, and this
could have influenced study findings. In addition, none of the 128 participants in this
study were considered to have LVH, according to the criterion utilized.
Aim Three
Aim three examined differences between blood pressure groups (elevated blood
pressure vs. non-hypertension) for dependent variables of HRV, QTc duration, and
Cornell voltage measures for LVH in overweight-obese adolescents. The results revealed
no significant difference between blood pressure groups for HRV measures (SDNN and
HF) and QTc Interval duration, but the elevated blood pressure group did exhibit higher
Cornell voltage measures for LVH than the non-hypertension group (p = 0.004).
Within this sample, 51% of the overweight-obese adolescents were hypertensive,
far exceeding research reporting that 30% of overweight children have elevated blood
pressure (McCarthy, Yancey, Siegel, Wong, Ward, Leslie, et al., 2008). In this sample of
overweight-obese adolescents, HRV measures of SDNN and HF were relatively similar
for both elevated blood pressure and non-hypertension groups. As previously addressed
literature reports when hypertension is present, SDNN measures of HRV are reduced
(Alter et al., 2006). No significant difference was identified for HRV measures of SDNN
or HF between the blood pressure groups. Kocak and colleagues (1999) suggest children
with hypertension have been identified to have an increased risk of developing QTc
prolongation. Within this study, no significant differences were noted between
adolescent blood pressure groups for QTc Interval duration. It should be noted however
that Franchi and colleagues (1996) reported that no differences were identified in HRV
measures or QTc Interval duration when mild hypertension was present. The elevated
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blood pressure group consisted of both the pre-hypertension and hypertension subjects
and the mean systolic and diastolic measures of blood pressure were not severe. Subjects
were also classified based on single rather than multiple blood pressure readings. Age and
gender variations have also been reported for HRV measures that might have influenced
study findings. Results of our study suggest that in youth elevations in blood pressure do
not further contribute to lower HRV measures or more prolonged QTc duration when
overweight-obesity is present.
Overweight-obese youth with elevated blood pressure had higher mean Cornell
voltage measures for LVH than non-hypertensive peers (0.95 mV vs. 0.76 mV),
respectively. This supports findings that in obese (Wilborn, Beckham, Campbell,
Harvey, Galbreath, La Bounty, et al., 2005) and non-obese (Liebson, 2002) subjects, an
association exists between elevation in blood pressure and LVH. Although no subjects in
this sample were considered to have LVH, there is a trend that should be examined to
identify adolescents at risk.
Aim Four
Aim four examined differences between black and white overweight-obese
adolescents for dependent variables of HRV, QTc duration, and Cornell voltage measures
for LVH. The results revealed no significant difference between black and white
overweight-obese adolescents for HRV measure of high frequency (HF), QTc duration,
or Cornell voltage measures for LVH, but a statistically significant difference (p = 0.000)
did exist for circadian fluctuation measures of SDNN between race groups.
SDNN is one of the most predictive values of HRV for mortality (Lampert et al.,
2005). The statistically lower measures of SDNN in blacks supports findings noted in
adults that minorities are more likely to have decreased SDNN than whites, and it has
been postulated to result from possible genetic differences or daily societal stress in the
minority population vs. whites (Lampert et al., 2005). However, our findings were
contrary to study findings that suggest no significant difference exists in SDNN between
healthy non-obese African American and white adolescents (Wang, Thayer, Treiber, &
Sneider, 2005), but obesity in this sample indicates a key difference from healthy
subjects. Altered autonomic function has been found already to be present in subjects
with a family history of hypertension (Wu, Lu, Yang, Lin, Chen, Wu, et al., 2008). In
our study, as noted above, 51% of participants were also hypertensive, and 60% of these
hypertensive subjects were black. Family history of hypertension was not examined,
which could have contributed to lower circadian fluctuations in blacks vs. whites.
There was no significant difference noted between black and whites for HF
measures of HRV in this study. In adults it has been reported that blacks have higher HF
measures than whites (Liao et al., 1995). Contrary findings in youth for HRV measures
identified lower HF measures in African American vs. whites in healthy adolescents
(Faulkner et al., 2003).
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Divergent results have been reported in regards to race for QT Interval
prolongation in blacks and whites. Though studies were not identified that examined this
factor in adolescents, in adults conflicting reports state that in blacks vs. whites QT
Interval duration is shorter (Dekker, et al., 2004), prolonged (Sgarbossa et al., 2000), and
not even affected by race (Peeters et al., 2008). In this study of black and white
overweight-obese youth, no significant difference was identified for QT Interval duration
between race groups. The overall marked obesity throughout the sample could have
contributed to this finding, because obesity is one of the most common causes of QT
prolongation (El Gamal et al., 1995).
Blacks have an increased incidence of LVH and elevated blood pressure than
whites (Coughlin, Gottdiener, Baughman, Wasserman, Marx, Tefft et al., 1994). No
significant differences were noted between black and white overweight-obese youth for
Cornell voltage measures for LVH. However, no participants were considered to have
LVH, regardless of race.
Strengths and Limitations
Strengths of this study include having a single blinded individual for analysis of
QTc duration and electrical voltage measurements for LVH. This increases consistency
and strengthens the study results as compared to analysis by multiple individuals. This
study utilized a 2-hour post glucose load as well as fasting glucose to determine IGT; this
method has been noted to be more effective than fasting glucose alone (Cruz et al., 2005).
An adequate sample size obtained from a larger study using secondary analysis of data
were a cost effective method, allowing the researcher to examine several variables in
overweight-obese adolescents. Because original data were collected within a 250-mile
radius of a metropolitan city, findings can be generalized to both urban and rural
populations. As noted, studies could not be identified that examined glucose tolerance,
hypertension, and race in overweight-obese adolescents in regards to HRV, QTc duration,
and electrical voltage criteria for LVH, and these findings will greatly contribute to this
identified gap in the literature.
Furthermore, several limitations also exist in association with the study design.
Secondary analysis of data is cost effective and beneficial but has drawbacks including
the potential for bias. This bias could be related to the fact that original data were not
collected to examine these variables within this population. The original data were
obtained from a larger study, which investigated potential racial differences associated
with IGT in overweight-obese youth, and although quite similar the original goals were
not aligned with the goals of this study. Another limitation is the inequality of groups
within the study: 71.9% of the sample had a normal glucose tolerance, 63.3% were
female, and 95.3% were considered obese, according to age and gender percentiles. The
researcher also had to assume that during the original study all data were collected
accurately, as specified in the study criteria. In addition, elevated blood pressure was
identified in subjects using a single blood pressure reading.
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Theoretical Implications
The conceptual model for this study identified a relationship among all
independent and dependent variables. Impaired glucose tolerance (pre-diabetes) is a
precursor for T2DM, which alters autonomic function and contributes to decreases in
HRV, prolongation of the QT Interval, and hypertension leading to LVH. This study
illustrates that IGT (pre- diabetes) had a small association to these variables, as compared
to normal glucose tolerant overweight-obese peers, but not significantly. The
relationship between elevation in blood pressure and the association to LVH in the model
is supported by study findings. The conceptual model hypothesized IGT may be
associated with decreased HRV, QTc prolongation, or LVH even prior to the
development of T2DM and findings do not support this theory. Additional factors may
have been present that were not identified in the model that could have affected the
variables studied. For example, physical fitness levels may influence HRV measures and
Buchheit, Platat, Oujaa, & Simon (2007) studied the effects of physical activity and
physical fitness in preadolescents for HRV and determined that even regular moderate
intense activities may produce favorable improvements in HRV measures. Exercise
induced LVH should also be considered, in which discontinuation of physical activity can
reverse the physiological adaptation of the heart enlargement (Escudero, Turfano,
Rebolledo, Pellegrini, & Lobrutto, 2004). The conceptual model associates obesity to all
independent and dependent variables, and it has been suggested within our study that
glucose tolerance, elevated blood pressure, and race may have no additive effect on HRV,
QTc duration, or Cornell voltage measures for LVH when obesity is present.
Clinical Practice Implications
It is important for healthcare providers to be aware that although no significant
differences existed within this study between overweight-obese youth with IGT in
comparison to normal glucose tolerance, IGT is a precursor for T2DM, and 21% of
obese adolescents have pre-diabetes (American Diabetes Association, 2009). Currently,
the American Diabetes Association is not recommending a screening for IGT in children,
because evidence does not support the early intervention would delay the onset of T2DM
(American Diabetes Association, 2009). But when adolescents are overweight-obese,
IGT may present at a young age and the transition to T2DM is shortened (Jolliffe &
Janssen, 2006). Therefore, in overweight-obese youth it is important to assess BMI and
RBMI accurately and follow-up with glucose tolerance testing if obesity is present,
because obesity in adolescents is significantly associated with abnormal glucose
(Plourde, 2006). Prevention is the most important element, and if in overweight-obese
adolescents IGT can be identified prior to its advancement to T2DM, alterations in
autonomic function leading to decreased HRV, QTc prolongation, and elevations in
blood pressure resulting in LVH may all be prevented.
Although a significant difference for QTc was not identified for glucose tolerance,
blood pressure, or racial groups, the prevalence of QTc prolongation in this sample of
34% exceeds that reported in obese adults of 26% (Rautaharju, P & Rautaharju, F.,
2007). Prolongation of the QT Interval can be acquired genetically, due to adverse drug
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reactions, and as hypothesized in accordance with obesity. Clinicians have always used
precaution when prescribing medications that may adversely affect QT duration,
especially to individuals with known QT prolongation. Findings from this study suggest
the need to consider overweight-obese adolescents at a high risk for QT prolongation
when medications are prescribed that affect QT duration and they should be monitored
accordingly. This supports the need for 12-lead electrocardiogram analysis in
overweight-obese youth to screen for QT prolongation.
The statistically significant difference noted in overweight-obese youth with
elevated blood pressure compared to those that were non-hypertensive for Cornell
voltage measures suggests that the pathological sequence that takes place in obese adults
may also be present in overweight-obese adolescents. But regardless of the pathological
sequence, research has identified that elevations in blood pressure in overweight-obese
adolescents predicts the need for early intervention strategies to prevent the development
of major health concerns (Torrance, McGuire, Lewanczuk, & McGavock, 2007). An
electrocardiogram is a simple and cost-effective screening tool that healthcare providers
could use to measure electrical voltage criteria for LVH in overweight-obese youth. Left
ventricular hypertrophy is present in a large percentage of individuals with hypertension
and accounts for an increased risk of sudden cardiac death (Liebson, 2002). Obtaining a
12-lead electrocardiogram in overweight and obese adolescents with elevated blood
pressure can lead to early identification and proper treatment.
In black overweight-obese adolescents, it is important for the healthcare provider
to be aware that decreased SDNN may identify individuals at risk for the development of
ventricular arrhythmias (Folino, Russo, Bauce, Mazzotti, & Daliento, 2004). Decreased
SDNN may lead to increased sympathetic modulation of the sinus node (Ozdemir, Alyan,
Soylu, Topaloglu, Aras, Metin, et al., 2006), which is associated with increased fatigued
and may contribute to threatening arrhythmias (Folino et al., 2004). However HRV
analysis remains questionable because optimal limits have not been set for clinical use
(Malik, 1996). In our study HRV measures of SDNN and HF would not be considered
as even moderately depressed and mean values were similar to those identified in healthy
non-obese youth (Faulkner et al., 2003). However it should be noted that differences in
literary results may be due to variations in sample sizes, differences in measurement
techniques, or the affects of physical activity levels on HRV measures.
Recommendations for Future Research
There were no studies identified that examined LVH in overweight-obese youth
using Cornell voltage criteria. Therefore, it was difficult to establish criteria to indicate
that LVH was present, so it was presumed to be more proper to examine the Cornell
electrical voltage measurements as a continuous variable for analysis and utilize the adult
criterion as a standard for reference. Research validating electrical voltage measures for
LVH through echocardiogram or magnetic resonance imaging in overweight-obese youth
is warranted to establish set criteria.
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Studies are also warranted to identify if family history of hypertension plays a
role in black overweight-obese adolescent’s susceptibility to autonomic dysfunction, as
identified in the Asian adult population. Within our study black overweight-obese youth
were noted to have decreased SDNN HRV measures in comparison to white peers, and it
would be important to understand the impact that family history of hypertension may
have on altered autonomic function within this group as well.
Age and gender differences have been reported to exist for HRV measures, and a
larger sample size for sub-analysis would prove to be beneficial. In addition, the overall
marked elevation of BMI and RBMI throughout the entire sample warrants future
investigation with a more varied weight group, with possible inclusion of healthy weight
subjects. This could decrease clustering of BMI and RBMI values. Also, future studies
that measure resting blood pressure on three various days of assessment are warranted.
This would allow the researcher to determine blood pressure status based upon the
recommended National High Blood Pressure Education Program Working Group on
High Blood Pressure in Children and Adolescents standards.
Conclusions
The positive associations between elevated blood pressure and electrical voltage
measurements for LVH in overweight-obese adolescents support findings reported in
other populations. In addition, although the direct relationship for decreased SDNN
(circadian fluctuation) HRV measures in black overweight-obese adolescents is
unknown, study findings are consistent with adult study findings within blacks and
whites. These findings also identify notable differences found in the overweight-obese
group as compared to studies of SDNN in healthy black and white adolescents. Minimal
differences were noted in regards to glucose tolerance, blood pressure, and race for this
group of overweight-obese adolescents, and results support findings that obesity alone is
an independent risk factor for cardiovascular disease (Wilborn et al., 2005). Further
studies examining glucose tolerance, blood pressure, and race in adolescents across a
more varied weight group are warranted to determine if these factors have an impact on
HRV, QTc duration, or electrical voltage criteria for LVH.
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